Documento,Palavra1,Palavra2,Palavra3,...
Documento 1,Sweat,8,'rusters,',8,control,persons,examined,sodium,concentration,.,Sweating,induced,iontophoresis,pilocarpine,distal,forearm,.,case,concentrations,exceed,normal,upper,limit,procedure,,,difference,found,two,groups,.,way,study,failed,confirm,earlier,reports,elevated,sodium,chloride,concentrations,sweat,'rusters,',.,Proposals,relationship,'rusters',patients,pancreatic,cystic,fibrosis,substantiated,.,Hyperhidrosis,palms,volar,surfaces,fingers,present,'rusters,',.,seemed,main,cause,corrosive,tendency,,,patients,referred,palmar,hyperhidrosis,found,produce,corrosion,similar,'rusters,',.,Topical,application,aluminium,chloride,hexahydrate,25,%,solution,absolute,ethyl,alcohol,proved,effective,hyperhidrosis,corrosive,tendency,.
Documento 2,111,patients,cystic,fibrosis,(,CF,),,,aged,7,months,29,years,,,examined,detect,inflammatory,middle,ear,diseases,.,35,%,history,one,attacks,acute,otitis,media,,,incidence,level,non-CF,patients,.,None,chronic,suppurative,otitis,.,4,88,patients,able,cooperate,audiometry,hearing,impairment,.,2,,,hearing,loss,perceptive,,,3,mild,,,fourth,case,,,moderately,severe,.,middle,ear,pressure,measured,108,patients,,,86,proved,normal,.,15,patients,middle,ear,pressure,lower,--,100,mmH2O,,,indicating,tubal,occlusion,,,7,patients,impedance,minimum,lacking,,,indicating,accumulation,mucus,.,7,patients,(,6,%,),secretory,otitis,media,.,Nasal,polyps,present,32,%,.,correlation,nasal,polyps,tubal,occlusion,secretory,otitis,.,incidence,inflammatory,middle,ear,diseases,CF,patients,range,non-CF,patients,,,finding,variance,previous,investigations,showing,middle,ear,pathology,25,--,48,%,.
Documento 3,Serum,normal,persons,133,cystic,fibrosis,patients,examined,precipitins,faecal,bacteria,(,E.,coli,B.,fragilis,),P.,aeruginosa,means,crossed,immunoelectrophoresis,.,27,%,normal,sera,contained,1-2,precipitins,E.,coli,,,16,%,contained,one,precipitin,B.,fragilis,6,%,contained,one,precipitin,P.,aeruginosa,.,sera,cystic,fibrosis,patients,,,significantly,increased,prevalence,precipitins,E.,coli,(,76,%,),,,B.,fragilis,(,38,%,),P.,aeruginosa,(,63,%,),,,mean,number,precipitins,bacteria,3,(,range,:,1-12,),,,1.4,(,range,:,1-4,),,,16,(,range,:,1-60,),,,respectively,.,Increased,numbers,precipitins,P.,aeruginosa,correlated,chronic,lung,infection,caused,species,poor,prognosis,,,whereas,associations,revealed,regards,precipitins,two,bacterial,species,.,Increased,numbers,precipitins,E.,coli,B.,fragilis,significantly,associated,increased,numbers,precipitins,P.,aeruginosa,.,suggested,association,due,immune,reactions,intestinal,mucosa,,,resulting,increased,absorption,antigens,gut,.
Documento 4,coexistence,cystic,fibrosis,(,CF,),coeliac,disease,(,CD,),reported,eight,children,,,odds,occurring,child,1:2,million,1:5.9,million,.,Sweden,,,would,around,1:3,million,(,incidence,CF,1:3000,CD,1:1000,),.,coexistence,two,diseases,thought,chance,,,although,CF,might,predispose,development,CD,.,10-year,period,(,33405,live,births,),,,observed,three,children,exocrine,pancreatic,insufficiency,small,intestine,dysfunction,.
Documento 5,Serum,sputum,sol,phase,23,patients,cystic,fibrosis,(,CF,),examined,occurrence,titres,precipitins,Haemophilus,influenzae,Staphylococcus,aureus,means,crossed,immunoelectrophoresis,intermediate,gel,.,patients,four,nine,H.,influenzae,precipitins,serum,cases,fewer,precipitins,sputum,,,,,average,,,difference,titres,antibodies,serum,sputum,.,antibodies,cross-reactive,species,,,notably,Haemophilus,genus,.,S.,aureus,precipitins,generally,found,higher,numbers,serum,sputum,,,,,average,,,titre,precipitins,sputum,higher,serum,.,Three,precipitins,detectable,sputum,serum,,,one,S.,aureus-specific,precipitin,.,antibodies,cross-reactive,species,,,antibodies,often,present,sputum,much,higher,titres,corresponding,sera,.,Antibodies,teichoic,acid,S.,aureus,cell,wall,could,demonstrated,sputum,,,present,22,sera,.,possible,role,local,pulmonary,humoral,immune,response,protective,immunity,pathology,lung,disease,CF,discussed,.
Documento 6,Eleven,cystic,fibrosis,(,CF,),patients,chronically,infected,lungs,mucoid,Pseudomonas,aeruginosa,presenting,multiple,precipitins,serum,bacterium,(,CF,+,P,),10,CF,patients,without,P.,aeruginosa,infection,(,CF-P,),serum,sputum,sol,phase,specimens,examined,antibodies,IgA,IgG,classes,surface,antigens,P.,aeruginosa,means,indirect,immunofluorescence,technique,.,IgA,IgG,antibody,titres,demonstrated,serum,sputum,CF,+,P,patients,significantly,higher,CF-P,patients,(,p,less,0.01,),.,titre,IgA,antibodies,sputum,higher,serum,3,cases,indicating,local,pulmonary,production,specific,IgA,antibodies,.,role,demonstrated,antibodies,local,pulmonary,immune,defense,mechanisms,possible,patogenesis,pulmonary,tissue,damage,CF,patients,discussed,.
Documento 7,14,cystic,fibrosis,(,CF,),patients,chronically,infected,mucoid,P.,aeruginosa,presenting,multiple,precipitins,serum,bacterium,(,CF,+,P,),13,CF,patients,without,P.,aeruginosa,infection,(,CF-P,),plasma,sputum,sol,phase,examined,albumin,,,Clq,.,C3/C3c,,,C4,C5,means,electroimmunoassays,.,sputum,sol,phase,examined,also,factor,B,rocketimmunoelectrophoresis,.,C3c,demonstrated,sputum,sol,phase,significantly,frequent,(,p,less,0.01,),among,CF,+,P,patients,among,CF-P,patients,.,Factor,B,also,demonstrated,sputum,sol,phase,,,significant,difference,frequency,could,demonstrated,CF,+,P,CF-P,patients,.,None,results,indicated,local,pulmonary,production,complement,factors,took,place,.,Complement,activation,significantly,(,p,less,0.01,),associated,inflammation,expressed,increased,(,formula,:,see,text,),.,results,show,importance,complement,mediated,inflammation,pathogenesis,pulmonary,tissue,damage,patients,CF,support,concept,chronic,P.,aeruginosa,lung,infection,immune,complex,disease,CF,patients,.
Documento 8,Sera,89,patients,cystic,fibrosis,(,CF,),88,control,persons,examined,occurrence,rheumatoid,factors,(,RF,),IgG,,,IgA,IgM,classes,indirect,immunofluorescence,method,latex,fixation,slide,test,.,prevalence,RF-IgG,significantly,higher,(,88,%,),(,p,less,0.0005,),among,CF,patients,among,control,persons,(,7,%,),,,difference,found,two,groups,regard,RF,IgA,IgM,classes,.,Fifty-five,CF,patients,chronic,Pseudomonas,aeruginosa,infection,lungs,two,precipitins,bacteria,sera,determined,crossed,immunoelectrophoresis,.,CF,patients,differ,34,CF,patients,without,chronic,P.,aeruginosa,infection,,,neither,regard,prevalence,titer,RFs,,,positive,correlation,number,P.,aeruginosa,precipitins,55,chronically,infected,CF,patients,titers,IgG-RF,.,Nineteen,CF,patients,examined,also,RFs,,,antinuclear,antibodies,(,ANA,),anti-DNA,antibodies,sputum,sol,phase,corresponding,sera,.,RFs,demonstrated,sputum,sol,phase,6,patients,latex,fixation,test,,,whereas,sera,negative,test,,,possibly,indicating,local,production,RF,.,Positive,reactions,ANA,anti-DNA,antibodies,found,7,10,sputa,respectively,,,higher,titers,corresponding,sera,,,also,suggesting,local,production,.,Titers,autoantibodies,sputum,low,difference,found,patients,chronic,P.,aeruginosa,infection,patients,without,P.,aeruginosa,infection,.,possible,role,autoantibodies,patogenesis,pulmonary,tissue,damage,CF,patients,discussed,.
Documento 9,Oral,zinc,supplementation,100,mg,zinc,sulfate,8-week,period,36,patients,cystic,fibrosis,17,siblings,affect,vitamin,transport,system,,,evidenced,absence,consistent,significant,quantitative,changes,plasma,levels,vitamin,,,retinol-binding,protein,,,zinc,,,exogenous,zinc,appear,stimulate,growth,exert,clinical,benefit,cystic,fibrosis,patients,.,lack,response,zinc,supplementation,might,explained,fact,group,cystic,fibrosis,subjects,studied,fairly,healthy,regard,clinical,status,certain,blood,parameters,,,including,zinc,.
Documento 10,Fecal,fat,,,bile,acids,,,rectal,microflora,studied,seven,control,children,three,groups,patients,cystic,fibrosis,(,CF,),.,Seven,antibiotics,,,ten,oral,cloxacillin,,,six,i.v,.,triple,therapy,(,cloxacillin,,,gentamycin,,,carbenicillin,),least,2,weeks,.,Controls,lower,concentrations,(,milligrams,per,gram,dry,stool,),fat,(,P,<,0.005,),vile,acids,(,P,<,0.025,),CF,children,antibiotics,.,Antibiotics,little,effect,fat,led,striking,decrease,(,P,<,0.01,),bile,acids,triple,therapy,group,.,Concomitantly,,,reduced,deconjugation,bile,acids,(,P,<,0.01,),formation,secondary,bile,acids,(,P,<,0.005,),.,associated,5-fold,increase,percentage,bile,acids,found,aqueous,phase,stools,marked,reduction,(,P,<,0.001,),anaerobic,flora,(,log,counts,per,gram,wet,stool,),children,triple,therapy,(,4.3,plus,minus,1.9,),compared,controls,(,9.8,plus,minus,0.1,),,,CF,antibiotics,(,9.1,plus,minus,0.1,),CF,cloxacillin,(,9.6,plus,minus,0.2,),.,close,relationship,anaerobic,flora,,,extent,bile,acid,microbial,transformation,,,fecal,bile,acid,concentrations,suggest,reduction,anaerobic,flora,decreases,adsorption,bile,acids,dietary,residues,microbes,,,favors,bile,acid,absorption,,,leads,decreased,fecal,loss,bile,acids,CF,.
Documento 11,Measurements,serum,bile,acids,(,glycine,conjugates,cholic,,,chenodeoxycholic,,,deoxycholic,,,lithocholic,acids,),radioimmunoassay,variety,pediatric,hepatobiliary,disorders,showed,elevations,neonatal,hepatitis,syndromes,,,cholestasis,,,hepatitis,extrahepatic,intrahepatic,origin,.,Measurements,individual,serum,bile,acids,failed,differentiate,various,neonatal,hepatitis,syndromes,.,one,patient,cholestasis,,,increased,levels,bile,acids,observed,returned,normal,following,therapy,cholestyramine,phenobarbital,.,chronic,active,hepatitis,serum,bile,acid,values,correlated,well,bilirubin,SGOT,response,therapy,corticosteroids,.,data,confirm,suggestions,serum,cholylglycine,chenodeoxycholylglycine,levels,sensitive,indicator,disturbed,hepatic,function,used,monitoring,course,,,activity,,,therapeutic,response,various,hepatitis,syndromes,.,Reye,'s,syndrome,protracted,diarrhea,infancy,,,elevations,serum,bile,acids,detected,without,associated,hyperbilirubinemia,provided,additional,evidence,disturbed,hepatic,function,.
Documento 12,chloride,electrode,sweat,test,gravimetric,chloride,titration,technic,compared,.,two,technics,gave,comparable,mean,values,,,ogives,,,equivalent,points,,,overlap,patients,cystic,fibrosis,healthy,subjects,.,single,test,either,technic,unacceptable,risk,false-positive,false-negative,results,,,tests,always,done,pairs,.,statistical,interpretation,technic,based,prevalence,technical,variability,two,tests,decrease,number,undiagnosed,subjects,define,probability,cystic,fibrosis,undiagnosed,group,.
Documento 13,Potential,sources,error,Gibson,Cooke,method,sweat,testing,using,gauze,filter,paper,collection,media,described,.,absolute,chloride,content,gauze,higher,filter,paper,;,however,,,variability,chloride,contents,two,insignificant,.,Complete,chloride,elution,filter,paper,requires,time,elution,gauze,.,method,determining,probability,clinically,acceptable,measurement,based,sweat,sample,size,,,chloride,determination,,,variability,chloride,collection,media,also,described,.
Documento 14,Bone,mineral,content,,,bone,width,,,ratio,measured,patients,cystic,fibrosis,(,CF,),using,monoenergetic,photon,absorptiometry,.,Serial,measurements,radius,ulna,made,27,patients,CF,compared,968,age-matched,controls,.,Demineralization,found,37,%,boys,63,%,girls,.,Patients,age,10,years,normal,bone,mineral,content,nine,15,patients,aged,13,older,demineralized,(,P,less,.01,),.,Demineralization,correlated,extent,weight,reduction,patients,(,P,less,.001,),.,Patients,likely,demineralized,adolescent,girls,.,knowledge,,,first,report,bone,mineral,status,children,CF,,,results,indicate,sizable,proportion,patients,may,demineralized,without,overt,rickets,.
Documento 15,article,describes,first,time-limited,psychosocial,support,group,adults,cystic,fibrosis,(,CF,),.The,chronology,group,traced,,,focusing,issues,importance,health,professionals,work,patients,CF,.,issues,raised,patient,members,include,doubts,competence,nonpediatricians,adequately,treat,CF,;,resentment,towards,``,normals,'',(,without,CF,),,,including,health,professionals,;,desire,control,many,areas,lives,possible,.,Covert,(,ie,,,unrecognized,),issues,,,role,staff,,,risks,,,outcome,detailed,guide,others,may,wish,conduct,groups,.,literature,groups,medical,patients,rationale,beneficial,effects,group,given,.
Documento 16,Cystic,fibrosis,common,cause,chronic,obstructive,pulmonary,disease,(,COPD,),pancreatic,insufficiency,first,three,decades,life,United,States,.,report,describe,75,patients,cystic,fibrosis,aged,18,47,years,review,another,232,cases,reported,literature,.,307,patients,elevated,sweat,chloride,sodium,levels,,,proved,excellent,discriminants,cystic,fibrosis,even,patients,older,age,group,.,COPD,,,present,97,per,cent,,,major,cause,morbidity,mortality,,,differed,COPD,etiologies,.,progressive,downhill,course,patients,punctuated,recurrent,symptomatic,exacerbations,chronic,bacterial,bronchitis,caused,Pseudomonas,aeruginosa,Staphyloccocus,aureus,,,terminated,pulmonary,insufficiency,,,cor,pulmonale,death,.,COPD,complicated,minor,hemoptysis,60,per,cent,,,massive,hemoptysis,7,per,cent,pneumothorax,16,per,cent,,,problems,rare,children,.,Sinusitis,present,examined,roentgenographically,,,48,per,cent,nasal,polyposis,.,Pancreatic,insufficiency,present,95,per,cent,patients,,,contrast,younger,patients,seldom,symptomatic,although,steatorrhea,azotorrhea,still,massive,.,Intussusception,meconium,ileus,equivalent,(,fecal,accumulation,),frequent,adults,(,21,per,cent,),rare,children,,,require,immediate,diagnostic,therapeutic,intervention,enemas,diatrizoate,sodium,.,Glycosuria,,,biliary,cirrhosis,,,cholelithiasis,aspermia,among,complications,.,Height,weight,usually,within,lower,limits,normal,,,17,per,cent,men,180,cm,height,7,per,cent,overweight,.,Therefore,,,high,index,suspicion,needed,make,diagnosis,,,older,patients,cystic,fibrosis,may,look,quite,well,.
Documento 17,development,exocrine,pancreas,determined,quantitatively,31,infants,cystic,fibrosis,(,CF,),without,meconium,ileus,29,control,infants,.,normal,pancreas,,,ratio,acinar,connective,tissue,volume,0.5,32,weeks,postconceptional,age,(,PCA,),increases,linearly,2.0,52,weeks,PGA,.,cystic,fibrosis,infants,,,without,meconium,ileus,,,ration,0.5,35,weeks,PCA,anddecreases,linearly,0.3,52,weeks,PCA,.,volume,acinar,duct,lumens,greater,CF,control,infants,independent,age,acinar,volume,.,development,exocrine,pancreas,infants,CF,without,meconium,ileus,diverges,normal,pattern,:,consistent,lack,exocrine,tissue,full-term,birth,,,persists,throghout,age,range,study,.,CF,infants,42,weeks,PCA,discriminated,controls,basis,quantitative,assessment,acinar,volume,.
Documento 18,investigate,contribution,vagal,tone,obstructive,airway,disease,cystic,fibrosis,,,evaluated,pulmonary,function,response,administration,0.1,mg,atropine,sulfate,per,kg,body,weight,,,0.05,mg,isoproterenol,hydrochloride,per,kg,body,weight,,,isotonic,saline,(,control,solution,),administered,nebulization,3,different,days,10,patients,cystic,fibrosis,single,blind,study,.,doses,atropine,sulfate,isoproterenol,hydrochloride,based,published,dose-response,characteristics,drugs,.,day,,,thoracic,gas,volume,airway,resistance,measured,volume,displacement,body,plethysmograph,,,maximal,expiratory,flow-volume,curves,performed,15,,,30,,,60,min,inhalation,.,inhalation,saline,,,group,mean,values,pulmonary,functions,indicated,greater,airway,obstruction,15,,,30,,,60,min,compared,pretreatment,values,.,inhalation,isoproterenol,atropine,,,significant,improvement,(,P,<,0.05,),noted,maximal,expiratory,flows,60,per,cent,total,lung,capacity,,,specific,airway,conductance,,,thoracic,gas,volume,,,residual,volume,.,Inhalation,atropine,also,significantly,improved,maximal,expiratory,flow,25,per,cent,vital,capacity,.,Isoproterenol,increased,mean,flows,8,46,per,cent,baseline,,,decreased,thoracic,gas,volume,residual,volume,11,16,per,cent,maximal,response,15,30,min,.,Atropine,increased,mean,flows,15,77,per,cent,decreased,thoracic,gas,volume,residual,volume,16,25,per,cent,maximal,effect,30,60,min,.,mean,response,atropine,,,expressed,percentage,baseline,,,always,greater,equal,isoproterenol,.,conclude,vagal,tone,,,may,reflect,increased,irritant,receptor,activity,,,contributes,obstructive,pulmonary,function,cystic,fibrosis,.,Inhalation,atropine,sulfate,decrease,pulmonary,function,abnormality,,,side,effects,prohibit,clinical,usefulness,.
Documento 19,Forty-six,patients,cystic,fibrosis,(,CF,),studied,colonization,sensitization,Aspergillus,organisms,.,fungus,cultured,21,37,(,57,%,),patients,produced,sputum,.,non-CF,sputum,isolation,rate,6.5,%,.,Sputum,hyphae,seen,95,%,patients,positive,cultures,.,Sputum,eosinophilia,accompanied,colonization,Aspergillus,.,Aspergillus,precipitins,found,37,%,CF,patients,;,positive,immediate,skin,tests,found,39,%,.,``,Atopy,'',defined,skin,test,criteria,found,46,%,.,findings,common,patients,severe,disease,(,p,less,0.05,),.,CF,patients,predominant,mold,sensitivity,contrast,predominant,pollen,sensitivity,control,group,asthmatic,subjects,.,Serum,IgE,concentrations,increased,22,%,CF,patients,.,CF,patients,increased,serum,concentrations,IgE,likely,family,history,atopy,.,Wheezing,common,atopic,,,especially,group,predominant,mold,sensitivity,severe,disease,.,Four,patients,fulfilled,diagnostic,criteria,allergic,bronchopulmonary,aspergillosis,(,ABPA,),time,study,follow-up,.,fifth,patient,ABPA,diagnosed,study,.,incidence,ABPA,2-yr,period,CF,population,11,%,.
Documento 20,Flows,measured,maximal,expiratory,flow-volume,(,MEFV,),curves,used,evaluate,efficacy,postural,drainage,improving,ventilatory,function,acutely,.,Maximal,expiratory,flow-volume,curves,obtained,9,cystic,fibrosis,subjects,10,subjects,chronic,bronchitis,5,,,15,,,45,min,30-min,session,postural,drainage,percussion,,,vibration,,,coughing,.,Forced,vital,capacity,(,FVC,),significantly,increased,45,min,drainage,combining,group,.,Flows,high,lung,volumes,different,2,subgroups,.,Subjects,cystic,fibrosis,demonstrated,significant,increase,peak,expiratory,flow,rates,45,min,drainage,increase,forced,expiratory,volume,one,sec,time,intervals,.,subjects,chronic,bronchitis,decreased,peak,expiratory,flow,rate,5,min,drainage,,,45,min,,,returned,baseline,.,significant,change,one-sec,forced,expiratory,volume,time,interval,chronic,bronchitis,subgroup,.,Changes,flows,low,lung,volumes,similar,2,subgroups,.,Forty-five,min,drainage,increase,flow,rates,near,50,per,cent,FVC,.,Flows,near,25,per,cent,FVC,increased,15,45,min,drainage,.,study,demonstrated,postural,drainage,coughing,resulted,significant,improvement,flows,low,lung,volumes,.,Changes,flows,high,lung,volumes,less,consistent,.
Documento 21,Responses,treadmill,exercise,36,patients,cystic,fibrosis,studied,evaluate,usefulness,identifying,atopy,.,Ten,36,patients,cystic,fibrosis,(,28,%,),abnormal,response,exercise,frequent,atopic,characteristics,normal,exercise,responses,.,Response,treadmill,exercise,alone,identify,patients,atopic,disease,among,cystic,fibrosis,.
Documento 22,review,describes,development,application,novel,test,determine,levels,human,immunoreactive,trypsin,,,enzyme,produced,solely,pancreas,,,biological,fluids,.,organ-,specific,,,assay,immunoreactive,trypsin,ideal,marker,pancreatic,function,,,supported,results,number,clinical,research,investigations,.,Use,assay,studies,chronic,pancreatitis,,,juvenile-onset,diabetes,,,cystic,fibrosis,yielded,much,valuable,data,,,expected,research,lead,improved,understanding,conditions,associated,pancreas,health,disease,.
Documento 23,flexible,bronchoscope,Fogarty,balloon,irrigating,catheters,used,effectively,manage,treat,hemoptysis,series,patients,cystic,fibrosis,.,procedure,well,suited,patients,,,prone,recurrent,hemoptysis,,,may,also,indicated,inoperable,patient,poor,cardiopulmonary,reserve,.
Documento 24,Minimal,inhibitory,concentrations,carbenicillin,,,chloramphenicol,,,tetracycline,,,gentamicin,,,tobramycin,,,trimethoprim-,sulfamethoxazole,determined,rough,,,smooth,,,mucoid,Pseudomonas,sp,.,isolates,sputa,collected,40,cystic,fibrosis,patients,.,Ninety-four,percent,minimal,inhibitory,concentrations,obtained,using,mixed,inocula,colonies,different,morphological,types,fell,within,one,serial,dilution,resistant,minimal,inhibitory,concentration,obtained,colony,type,tested,separately,.
Documento 25,province,Limburg,,,newborn,babies,screened,metabolic,anomalies,:,amino,acidopathies,since,1968,,,galactosemia,since,1974,mucoviscidosis,since,1978,.,127,676,newborns,,,12,cases,phenylketonuria,3,inherited,anomalies,.,meaningful,policy,government,neonatal,screening,necessarily,requires,good,organization,,,put,together,screening,data,,,diagnosis,,,treatment,follow-up,.
Documento 26,Chest,physiotherapy,still,remains,one,important,aspects,treatment,chest,complications,cystic,fibrosis,.,mechanical,device,allows,patient,cystic,fibrosis,chest,physiotherapy,great,benefit,effective,manual,percussion,.,14,patients,cystic,fibrosis,using,mechanical,manual,percussion,physiotherapy,studied,measuring,sputum,volumes,,,FEV,FVC,.,Results,mechanical,percussor,good,manual,percussor,,,therefore,,,would,reasonable,older,patient,use,former,.
Documento 27,4-year,routine,screening,programme,cystic,fibrosis,(,CF,),15,464,specimens,examined,raised,meconium,albumin,levels,test,strip,method,electroimmunoassay,.,incidence,false-,positive,results,5,per,1000,specimens,either,test,.,could,reduced,90,%,determining,ratio,albumin,:,alpha-1-,trypsin,inhibitor,(,ratio,2.0,considered,negative,result,),,,could,reduced,zero,determining,ratio,subsequent,faecal,specimens,.,Three,12,meconium,specimens,infants,proved,CF,gave,false-negative,results,3,tests,.,9,specimens,greater,100,mg,albumin/g,dry,weight,albumin,:,alpha-1-trypsin,inhibitor,ratios,greater,3.0,;,subsequent,faecal,specimens,ratios,4.0,.,176,meconium,specimens,elsewhere,UK,examined,included,23,infants,subsequently,proved,CF,.,Six,23,CF,specimens,gave,false-negative,results,,,17,strongly,positive,.,origins,meconium,serum,protein,suggest,infants,CF,meconium,gives,false-negative,results,normal,pancreatic,functions,birth,.,specificity,current,meconium,tests,therefore,improved,depend,pancreatic,dysfunction,.
Documento 28,child,cystic,fibrosis,asthma,developed,pulmonary,candidiasis,.,Predisposing,factors,patient,prolonged,antibiotic,therapy,,,high-dose,corticosteroids,,,intravenous,catherisation,.,diagnosis,made,lung,puncture,confirmed,rapid,response,5-fluorocytosine,.
Documento 29,quantitative,qualitative,distribution,bile,salts,duodenal,juice,13,patients,cystic,fibrosis,(,CF,),studied,test,meal,.,effects,triolein,(,),,,bovine,serum,albumin,(,BSA,),,,ricinoleic,acid,(,RA,),absorption,taurocholate,(,TCA,),distal,ileum,rat,vivo,also,studied,.,mean,(,ranges,),total,bile,salt,concentrations,,,glycine,:,taurine,conjugate,ratios,,,percentage,dihydroxy,bile,salts,patients,CF,pancreatic,insufficiency,3.5,(,1.3,--,6.6,),mmol/l,,,8.6,(,greater,10-3.1,),,,37,(,10,--,60,),compared,control,values,7.4,(,3.0,--,16.0,),mmol/l,,,3.0,(,1.3,--,4.5,),,,61,(,52,--,70,),respectively,.,differences,control,CF,values,statistically,significant,(,P,less,0.01,--,P,less,0.001,),.,Three,13,CF,patients,total,bile,salt,concentrations,less,2,mmol/l,,,8,much,higher,glycine,:,taurine,ratios,,,8,reduced,percentage,dihydroxy,bile,salts,.,2,patients,normal,pancreatic,enzyme,activities,,,duodenal,bile,salts,quantitatively,qualitatively,normal,.,(,10,30,mmol/l,),,,BSA,(,3,%,),,,RA,(,5,mmol/l,),inhibitory,effect,ileal,absorption,TCA,.,results,show,pronounced,abnormalities,duodenal,juice,bile,salts,CF,pancreatic,insufficiency,consistent,broken,enterohepatic,circulation,(,EHC,),;,abnormalities,may,contribute,defective,lipid,absorption,CF,.,data,experimental,animal,support,suggestion,unhydrolysed,dietary,substrates,play,role,pathophysiology,broken,EHC,.
Documento 30,episode,severe,small,intestinal,hemorrhage,occurred,cystic,fibrosis,patient,pancreatic,insufficiency,receiving,timed-,release,aspirin,therapy,disabling,hypertrophic,pulmonary,osteoarthropathy,.,increased,acidity,small,intestinal,contents,due,decreased,bicarbonate,secretion,observed,patients,pancreatic,insufficiency,may,alter,luminal,environment,result,mucosal,erosions,and/or,ulcerations,association,presence,aspirin,.,Thus,,,physicians,aware,possibility,timed-release,aspirin,causes,small,intestinal,hemorrhage,patients,.
Documento 31,21-year-old,patient,cystic,fibrosis,developed,bilateral,brain,abscesses,due,anaerobic,Streptococcus,.,rare,association,presents,interesting,etiologic,study,.
Documento 32,mucosal,epithelium,middle,ear,Eustachian,tube,direct,continuity,upper,respiratory,tract,.,Since,otolaryngological,aspects,cystic,fibrosis,(,CF,),dominated,involvement,paranasal,sinuses,,,might,assumed,children,CF,would,expected,higher,usual,incidence,middle,ear,disease,.,Eighty,patients,afflicted,CF,audiological,evaluations,,,consisted,hearing,threshold,levels,(,250,8,000,Hz,),speech,impedance,audiometry,.,found,greater,incidence,conductive,sensorineural,hearing,loss,patients,CF,compared,normal,age-adjusted,population,.
Documento 33,Adolescents,cystic,fibrosis,compared,normal,adolescents,age,educational,grade,several,measures,vocational,development,adjustment,.,cystic,fibrosis,group,ages,12,--,16,grades,7,,,8,,,9,scored,lower,normal,counterparts,measures,vocational,educational,plans,,,less,realistic,normals,considering,limitations,financial,constraints,.,contrast,,,cystic,fibrosis,group,nearly,age,grade,levels,scored,significantly,higher,strength,commitment,vocational,choice,,,work,values,,,awareness,occupational,information,.,Compared,4,additional,handicapped,groups,already,studied,,,adolescents,cystic,fibrosis,scored,favorably,.,plan,work,also,hold,strong,work,values,compared,normals,.,Rehabilitation,programs,emphasize,preparation,career,development,educational,vocational,plans,adolescent,still,high,school,.
Documento 34,6-E1,(,R,),-2-,(,oxo-imidazolidine-1-carboxamido,),-2-phenyl-acetamido,],-,penicillanic,acid,sodium,salt,(,azlocillin,,,Securopen,),given,doses,100,200,mg/kg,body,weight,children,cystic,fibrosis,.,intravenous,bolus,infections,,,serum,half-life,0.82,+/-,0.12,h,lower,dose,0.98,+/-,0.18,h,higher,dose,.,consequent,dose,limited,elimination,kinetics,due,limitation,renal,non-renal,processes,elimination,.,Upon,doubling,dose,100,200,mg/kg,,,total,body,clearance,dropped,13.93,5.10,1/h,.,Evaluation,data,presented,publications,indicate,dose,limited,elimination,kinetics,normal,situation,azlocillin,.,Besides,,,serum,concentrations,patients,cystic,fibrosis,considerably,lower,seen,healthy,state,.,reason,faster,elimination,renal,route,cystic,fibrosis,.
Documento 35,major,change,outlook,children,cystic,fibrosis,last,20,years,.,Provided,diagnosis,made,serious,irreversible,lung,disease,occurred,,,patients,expect,reach,adult,life,without,serious,disability,.
Documento 36,Patients,cystic,fibrosis,immunized,subunit,influenza,vaccine,haemagglutination-inhibiting,(,HI,),antibody,responses,compared,responses,young,healthy,adults,.,significant,difference,antibody,levels,reached,immunization,evidence,impairment,responses,patient,group,.
Documento 37,Cystic,Fibrosis,(,CF,),serum,isolated,component,IgG,fraction,produce,increased,uptake,45Ca++,rabbit,tracheal,explants,compared,control,serum,isolated,IgG,fraction,.,Heterozygote,serum,also,produced,increased,uptake,45Ca++,extent,CF,serum,.,calcium,channel,blocker,D600,inhibited,CF,serum,induced,uptake,45Ca++,indicating,CF,serum,may,acting,plasma,membrane,produce,changes,calcium,permeability,rabbit,tracheal,explants,.
Documento 38,novel,technique,employed,demonstrate,alpha-L-,fucosidase,purified,cystic,fibrosis,control,livers,exhibits,differential,binding,lectin,Concanavalin,.,concentration,alpha-CH3-mannoside,necessary,prevent,50,%,binding,alpha-L-fucosidase,Concanavalin,considerably,lower,cystic,fibrosis,enzyme,(,13.5,vs.,33.3,mM,),.,Comparable,results,found,binding,studies,done,crude,supernatant,alpha-L-fucosidase,8,cystic,fibrosis,8,control,livers,(,5.6,plus,minus,0.4,mM,13.2,plus,minus,3.4,respectively,),,,without,overlap,values,cystic,fibrosis,control,livers,.,results,suggest,comparative,lectin,binding,studies,cystic,fibrosis,normal,glycoproteins,readily,available,tissues,might,result,assay,detecting,cystic,fibrosis,genotype,.
Documento 39,membrane,glycoprotein,enzyme,,,alkaline,phosphatase,induced,cultured,human,fibroblasts,dibutyryl,cyclic,AMP,,,sodium,butyrate,,,serum,glycoprotein,fetuin,,,Tamm-Horsfall,urinary,glycoprotein,,,number,inhibitors,DNA,synthesis,.,uninduced,basal,enzyme,activity,increased,later,stages,growth,cells,became,confluent,.,Induction,dibutyryl,cyclic,AMP,fetuin,effective,agents,added,cells,reached,stationary,phase,maximal,least,two,days,exposure,.,levels,induction,resulting,addition,pairs,agents,,,dibutyryl,cyclic,AMP,,,n-butyrate,fetuin,additive,indicating,different,modes,action,.,inhibitors,DNA,synthesis,,,cytosine,arabinoside,,,hydroxyurea,,,methothrexate,less,effective,inducers,.,Bromodeoxyuridine,also,non-DNA,mediated,effects,induced,extent,dibutyryl,cyclic,AMP,.,Similar,experiments,sex-,age-matched,cell,strains,derived,patients,cystic,fibrosis,failed,detect,differences,levels,induction,observed,normal,cells,.,addition,,,combined,inductive,effects,Tamm-,Horsfall,glycoprotein,,,isoproterenol,theophylline,,,similar,normal,cystic,fibrosis,cells,.
Documento 40,lipid,composition,isolated,plasma,membranes,human,skin,fibroblasts,described,first,time,.,Plasma,membranes,number,strains,fibroblasts,patients,cystic,fibrosis,matched,normals,isolated,recently,described,procedure,analysed,major,phospholipid,classes,,,cholesterol,fatty,acids,.,differences,quantities,compounds,detected,cells,two,different,origins,.,fetal,calf,serum,used,supplement,growth,medium,contained,relatively,palmitoleate,oleate,less,stearate,membranes,.,also,consistent,differences,cystic,fibrosis,normal,membranes,terms,fatty,acid,compositions,individual,phospholipid,classes,.,Consistent,lack,chemical,change,lipids,membranes,cystic,fibrosis,cells,,,degree,fluorescence,polarization,diphenylhexatriene,,,index,fluidity,,,also,unchanged,.
Documento 41,Bronchial,artery,embolization,useful,palliative,treatment,life-threatening,haemoptyses,surgery,contra-indicated,.,Patients,presenting,haemoptyses,complicating,cystic,fibrosis,aspergilloma,embolized,.,Control,haemoptysis,achieved,former,,,late,recurrence,haemoptysis,latter,led,asphyxiation,.
Documento 42,force,impact,frequency,percussion,physiotherapists,parents,children,cystic,fibrosis,analysed,special,test,rig,incorporated,prototype,percussor,.,adult,volunteers,cadavers,maximum,intrathoracic,pressure,could,achieved,critical,frequency,mechanical,percussion,higher,reached,physiotherapists,parents,.,Consequently,percussor,redesigned,operate,optimum,frequency,.,discovered,percussor,pressed,firmly,enough,chest,,,maximum,intrathoracic,pressure,could,indicated,quivering,voice,.,continuing,study,intrathoracic,pressures,obtained,mechanically,manually,Salford,percussor,'s,produced,higher,pressures,physiotherapists,',maintained,constantly,,,physiotherapists,',efforts,results,varied,one,another,.,Hospital,domiciliary,use,percussor,shown,help,first,stage,physiotherapy,routine,patients,cystic,fibrosis,.,percussor,enable,adolescents,adults,treat,encourage,twice-daily,effective,chest,treatments,.,easy,apply,speed,efficiency,enable,parents,improve,quality,chest,therapy,younger,children,home,.,long-term,benefits,difficult,assess,nature,disease,.
Documento 43,Sixteen,patients,cystic,fibrosis,treated,conventional,physiotherapy,aided,assistant,.,results,compared,produced,physiotherapy,using,forced,expiration,technique,cleared,sputum,less,time,conventional,physiotherapy,.,sputum,less,time,conventional,physiotherapy,.,second,study,showed,assistant,improve,results,obtained,patient,performing,forced,expiration,technique,.,findings,mean,patients,cystic,fibrosis,rely,help,others,home,treatment,may,perform,effective,treatment,without,help,.,forced,expiration,technique,might,also,helpful,patients,chronic,bronchitis,,,asthma,,,bronchiectasis,.
Documento 44,Static,lung,volumes,(,VC,,,TLC,,,FRC,,,RV,),,,elastic,recoil,pressure,lungs,(,Pst,(,1,),100,,,90,,,60,%,TLC,),,,static,lung,compliance,[,Cst,(,1,),],,,specific,airway,conductance,FRC,level,(,Gaw/TGVex,),,,forced,expiratory,volume,first,second,(,FEV1,),,,maximal,expiratory,flows,(,Vmax,.,),25,50,%,VC,60,%,TLC,,,'',upstream,'',airway,conductance,(,Gus,),60,%,TLC,studied,28,patients,cystic,fibrosis,,,5,25,years,old,,,period,1,5,years,.,data,compared,individually,normal,values,,,related,body,height,form,regression,equations,expressed,percentage,predicted,values,.,indices,assessing,airway,function,,,Vmax,.,low,lung,volumes,,,Gus,60,%,TLC,,,RV,RV/TLC,functional,parameters,consistently,abnormal,.,Among,indices,characterizing,lung,elasticity,,,Pst,(,1,),60,%,TLC,abnormal,.,Generally,,,values,majority,lung,function,indices,[,VC,,,TLC,,,FRC,,,Pst,(,1,),],declined,growth,.,Vmax,.,lung,volumes,Gus,60,%,TLC,deteriorate,growth,probably,due,great,abnormality,parameters,already,young,patients,.,also,observed,lung,function,change,significantly,period,1,5,years,corresponding,10,cm,increase,body,height,.,However,,,period,,,lung,function,improved,subjects,,,change,50,%,cases,deteriorated,others,.
Documento 45,97,well-defined,strains,Pseudomonas,,,isolated,sputum,patients,cystic,fibrosis,(,CF,),,,minimum,inhibitory,concentration,(,MIC,),several,antibiotics,determined,broth,dilution,method,.,majority,strains,resistant,ampicillin,cephalothin,,,moderately,susceptible,carbenicillin,(,70,%,100,microgram/ml,),highly,susceptible,piperacillin,(,100,%,25,microgram/ml,,,88,%,6.25,microgram,60,%,3.12,microgram/ml,),.,pharmacological,properties,piperacillin,comparable,carbenicillin,,,expected,sputum,level,drug,adequate,treat,Pseudomonas,pulmonary,infections,.,lowest,concentration,tested,(,0.78,microgram/ml,),3,%,strains,susceptible,kanamycin,,,85,5,%,amikacin,,,95,%,gentamicin,,,98,%,tobramycin,,,80,%,colimycin,.,regard,clinically,attainable,concentrations,,,98.9,%,strains,susceptible,gentamicin,tobramycin,97.9,%,amikacin,,,96.9,%,colimycin,,,88.6,%,piperacillin,,,38,%,carbenicillin,,,25.7,%,kanamycin,,,12.3,%,ampicillin,,,1,%,cephalothin,.
Documento 46,echocardiographic,study,,,assessment,heart,children,cystic,fibrosis,shown,changes,occur,right,ventricle,also,left,ventricle,aorta,,,compared,normal,.,Echocardiograms,could,successfully,performed,34,37,patients,.,thickness,right,ventricular,anterior,wall,dimension,right,ventricular,cavity,abnormal,,,even,patients,mild,disease,(,National,Institutes,Health,[,NIH,],score,severity,disease,85,greater,),.,Larger,,,older,children,lower,NIH,score,disproportionately,larger,right,ventricular,anterior,walls,cavities,.,thickness,septal,wall,,,thickness,left,ventricular,posterior,wall,,,aortic,dimensions,increased,severe,disease,.,dimensions,left,ventricular,cavity,population,slightly,significantly,smaller,normal,systole,diastole,throughout,course,disease,.,study,demonstrates,echocardiography,effective,noninvasive,means,assessing,long-term,changes,children,cystic,fibrosis,.,changes,occur,sides,heart,appear,worsen,disease,progresses,.
Documento 47,study,demonstrates,clinical,feasibility,atraumatically,measuring,dynamic,regional,lung,function,tetrapolar,electrical,impedance,plethysmography,(,EIP,),pediatric,age,group,.,tetrapolar,electrode,system,used,ability,detect,local,baseline,pulsatile,impedance,changes,,,minimal,electrode-,tissue,impedance,interference,,,uniform,current,distribution,.,Studies,performed,4,children,4,15,years,old,various,pulmonary,diseases,presented,.,information,obtained,regional,ventilation,pulsatile,perfusion,EIP,found,agree,closely,pulmonary,ventilation,perfusion,scans,.,one,case,,,EIP,detected,pulsatile,perfusion,abnormalities,apparent,non-pulsatile,perfusion,scan,demonstrated,cineangiography,.,concluded,tetrapolar,EIP,provide,safe,,,reliable,regional,information,ventilation,perfusion,diseased,lungs,,,atraumatic,approach,,,technically,suitable,use,children,.
Documento 48,explain,single-breath,carbon,monoxide,diffusing,capacity,(,Dsb,),,,average,,,elevated,163,asthmatic,subjects,175,patients,cystic,fibrosis,,,simulated,elevation,ten,normal,subjects,perform,test,Dsb,inspiratory,obstruction,.,resulted,18,percent,increase,Dsb,corrected,pulmonary,volume,.,Inhalation,bronchodilator,drug,associated,relief,obstruction,fall,corrected,Dsb,31,asthmatic,subjects,change,either,obstruction,corrected,Dsb,17,patients,cystic,fibrosis,.,suggest,elevated,Dsb,asthma,cystic,fibrosis,partly,due,maximal,inspiration,obstructed,airways,.,requires,abnormally,negative,intrathoracic,pressures,,,increasing,pulmonary,capillary,blood,volume,,,,,thereby,,,increasing,Dsb,.
Documento 49,echographic,study,undertaken,evaluate,left,(,LV,),right,ventricular,(,RV,),function,30,patients,cystic,fibrosis,.,Echographic,recording,pulmonary,aortic,valve,echogram,permitted,measurement,phases,right,left,ventricular,systole,.,ratio,LV,preejection,period/LV,ejection,time,(,LPEP/LVET,),shortening,LV,internal,dimension,%,SID,employed,reflect,LV,function,,,RV,preejection,period/RV,ejection,time,(,RPEP/RVET,),excellent,correlation,pulmonary,artery,diastolic,pressure,.,RPEP/RVET,two,echographic,measurements,,,right,ventricular,wall,(,RVW,),internal,dimension,(,RVD,),compared,pulmonary,function,tests,clinical,scores,.,RPEP/RVET,correlated,well,percent,vital,capacity,(,%,VC,),,,r,=,-0.73,,,percent,residual,volume,(,%,RVol,),r,=,+0.72,,,clinical,score,,,r,=,-0.77,.,Multilinear,regression,RPEP/RVET,,,RVD,,,RVW,improved,correlation,%,VC,(,r,=,-0.80,),,,%,RVol,,,r,=,+0.82,,,clinical,score,,,r,=,-0.84,.,Patients,overt,right,heart,failure,exhibited,elevated,RPEP/RVET,(,mean,=,0.48,),compared,patients,right,heart,failure,(,mean,=,.33,),.,Marked,diminution,LV,function,present,two,patients,.,variety,cardiovascular,abnormalities,demonstrated,echographically,valuable,assessing,degree,cardiac,involvement,patients,cystic,fibrosis,.
Documento 50,Ten,fifteen,cystic,fibrosis,children,positive,skin,prick,tests,common,antigens,gave,immediate,bronchial,reaction,antigen,inhaled,,,five,also,gave,late,reaction,;,however,one,gave,history,asthma,.,antigen,commonly,eliciting,positive,skin,reaction,cystic,fibrosis,patients,Aspergillus,fumigatus,.,six,children,tested,antigen,bronchial,response,varied,,,two,negative,,,one,gave,immediate,reaction,three,gave,dual,(,immediate,late,),reaction,.,None,children,showed,characteristic,pattern,response,exercise,seen,asthmatic,patients,,,initial,rise,Peak,Expiratory,Flow,Rate,followed,fall,greater,14,%,resting,level,.,Two,patients,showed,abnormal,rise,Peak,Expiratory,Flow,Rate,exercise,,,pattern,described,previously,cystic,fibrosis,.,results,suggest,bronchial,allergy,,,immediate,late,completely,explain,susceptibility,asthma,,,factors,including,perhaps,type,bronchial,reactivity,shown,bronchoconstriction,exercise,may,required,.,However,majority,children,tested,bronchial,allergy,anti-,allergy,therapy,inhaled,sodium,cromoglycate,may,place,management,selected,patients,cystic,fibrosis,.
Documento 51,exposure,pancreatic,extract,(,PE,),,,four,parents,cystic,fibrosis,(,CF,),children,developed,immediate,hypersensitivity-like,symptoms,:,i.e,.,rhinoconjunctivitis,,,asthma,,,and/or,anaphylaxis,.,IgE,PE,demonstrated,subjects,skin,testing,,,leucocyte,histamine,release,radioallergosorbent,test,(,RAST,),.,serum,precipitating,antibodies,found,.,Bronchial,challenge,caused,immediate,asthmatic,response,.,delayed,asthmatic,response,hypersensitivity,pneumonitis-like,reaction,occurred,.,responsible,antigen,PE,induced,asthma,unknown,;,trypsin,failed,inhibit,PE-RAST,therefore,responsible,subjects,.,Caution,exercised,using,PE,skin,testing,bronchial,challenge,subjects,suspected,hypersensitivity,PE,.,Certain,measures,found,useful,preventing,occurrence,symptoms,four,subjects,.
Documento 52,1,.,proportions,saturated,polyunsaturated,fatty,acids,measured,erythrocytes,Cystic,Fibrosis,(,CF,),patients,along,two,membrane,bound,enzymes,ATPase,acetylcholinesterase,.,Linoleic,acid,found,significantly,decreased,arachidonic,acid,increased,CF,patients,.,proportion,saturated,fatty,acids,significantly,different,controls,.,adenosinetriphosphatase,activity,found,reduced,acetylcholinesterase,CF,patients,.
Documento 53,evaluted,measurement,urinary,4-hydroxyphenyl,acetic,acid,potential,screening,method,small-bowel,disease,bacterial,overgrowth,syndromes,360,unselected,acutely,ill,infants,children,.,Control,data,obtained,120,healthy,children,,,ages,1.5,15,years,,,general,medical,practice,,,48,healthy,infants,,,ages,one,five,years,,,local,day,nurseries,,,150,healthy,babies,,,ages,less,one,eight,days,.,Comparative,data,300,acutely,ill,hospitalized,babies,children,,,ranging,age,less,one,day,15,years,without,clinical,evidence,small-,bowel,disease,bacterial,overgrowth,syndrome,.,false-negative,results,2,%,false-positive,results,observed,.,Among,10,patients,whose,urinary,excretion,analyte,considered,abnormal,patients,Giardia,lamblia,infestation,,,ileal,resection,blind,loop,,,diseases,small,intestine,associated,bacterial,overgrowth,.,conclude,measurement,4-hydroxyphenylacetic,acid,excretion,useful,screening,diseases,.
Documento 54,sweat,test,,,correctly,performed,,,appears,reliable,,,results,found,unreliable,half,time,84,small,community,hospitals,assessed,.,reasons,inexperienced,untrained,technicians,,,infrequency,test,performance,,,use,unstandardized,equipment,,,lack,appropriate,standards,.,behooves,clinical,laboratory,directors,re-examine,standardize,procedures,use,recommendations,Cystic,Fibrosis,Foundation,.,Physicians,made,aware,current,situation,send,patients,laboratories,perform,test,reliably,.
Documento 55,Secretion,lysosomal,enzyme,beta-N-acetylglucosaminidase,(,EC,3.2.1.30,),normal,cystic,fibrosis,fibroblasts,compared,.,contrast,earlier,report,,,differences,found,either,rate,secretion,,,molecular,forms,enzyme,secreted,normal,fibroblast,cultures,cultures,initiated,patients,cystic,fibrosis,.,B,isoenzyme,beta-N-,acetylglucosaminidase,cystic,fibrosis,fibroblasts,converted,negatively,charged,form,preincubation,3,h,pH,5.0,37,degrees,C.,enzyme,normal,fibroblasts,unaffected,treatment,.
Documento 56,study,eight,glycosidases,serum,samples,72,cystic,fibrosis,patients,,,85,cystic,fibrosis,parents,34,healthy,diseased,controls,,,significant,elevations,mean,alpha-glucosidase,levels,found,cystic,fibrosis,patients,.,glycosidases,show,significant,change,.,Mean,alpha-glucosidase,levels,obligate,heterozygotes,control,individuals,.,Moreover,,,alpha-glucosidase,levels,cystic,fibrosis,patients,correlated,degree,clinical,impairment,measured,Schwachman,score,.
Documento 57,Enzyme,activity,hippuryl-L-arginine,studied,cultured,skin,fibroblasts,controls,cystic,fibrosis,patients,.,enzyme,lysosomal,distribution,acid,optimum,pH,4.5,little,activity,present,pH,7.0,.,Dithiothreitol,required,full,activity,kinetics,thiol,activation,different,control,cystic,fibrosis,enzyme,.,properties,lysosomal,distribution,enzyme,indicated,carboxypeptidase,B.,Substrate,affinity,,,thermolability,,,pH,stability,,,fall,rise,activity,subculture,,,cyclical,pattern,activity,serial,passage,level,activity,similar,control,cystic,fibrosis,enzyme,.
Documento 58,Purified,preparations,plasma,alpha,2-macroglobulin,patients,cystic,fibrosis,shown,normal,amounts,total,hexose,much,40,%,decrease,sialic,acid,content,.,binding,preparations,concanavalin,wheat-germ,agglutinin,markedly,reduced,compared,normal,values,controls,.,Intermediate,values,found,obligate,heterozygotes,.,results,suggest,possible,alteration,carbohydrate,moiety,alpha,2-macroglobulin,cystic,fibrosis,,,presumably,due,defective,posttranslational,process,.
Documento 59,activity,alpha-L-fucosidase,decreased,serum,cystic,fibrosis,patients,compared,age-matched,controls,.,result,,,combined,elevated,activity,skin,fibroblasts,,,supports,concept,abnormal,intracellular,extracellular,distribution,alpha-L-fucosidase,cystic,fibrosis,.
Documento 60,Young,adults,cystic,fibrosis,good,excellent,condition,reduced,plasma,sodium,chloride,elevated,plasma,potassium,compared,group,healthy,young,adult,control,subjects,.,Blood,pressure,also,lower,patients,cystic,fibrosis,.,However,,,plasma,norepinephrine,dopamine-beta-hydroxylase,response,standing,isometric,hand,grip,normal,cystic,fibrosis,patients,.
Documento 61,Cultured,skin,fibroblast,primary,amniotic,fluid,cell,alpha-L-,fucosidase,double,optimum,pH,5.0,6.0,.,Alpha-L-fucosidase,largely,bound,single,peak,DEAE-cellulose,pH,6.6,.,Sucrose,density,isoelectric,focusing,revealed,seven,components,pI,values,4.9,,,5.2,,,5.4,,,5.8,,,6.1,,,6.5,7.1,apparent,KM,values,(,77,--,500,mumol/l,),higher,(,57,mumol/l,),unfocused,enzyme,.,Liver,,,skin,fibroblast,amniotic,fluid,cell,alpha-L-fucosidase,separated,two,peaks,gel,filtration,.,Peak,one,active,stable,low,pH,thermostable,50,degrees,C,peak,two,,,peaks,apparent,KM,52,mumol/l,.,Apart,different,proportions,peaks,separated,gel,filtration,,,results,three,tissues,similar,.,properties,alpha-L-fucosidase,studied,similar,control,cystic,fibrosis,liver,skin,fibroblasts,.
Documento 62,Forty-four,patients,cystic,fibrosis,,,sixty-seven,parents,,,thirty-nine,controls,compared,regard,immediate,cutaneous,hypersensitivity,,,total,specific,serum,IgE,serum,IgG4,concentrations,.,patients,increased,prick,test,reactions,specific,IgE,Aspergillus,fumigatus,.,development,reactions,A.,fumigatus,correlated,severity,disease,.,significant,differences,serum,total,IgE,,,specific,IgE,IgG4,concentrations,skin,test,reactivity,compared,patients,,,parents,controls,.
Documento 63,Tests,demonstrate,preference,mosquitoes,stinging,controls,opposed,obligate,heterozygotes,Cystic,Fibrosis,proved,negative,.,heterozygote,advantage,caused,lower,malarial,incidence,carriers,South,West,Africa,,,must,worked,malarial,parasite,adversely,affected,serum,factor,.,remains,tested,.
Documento 64,Serum,95,patients,cystic,fibrosis,47,control,subjects,without,cystic,fibrosis,analyzed,carboxypeptidase,B-like,activity,presence,optimal,concentrations,Co2+,ion,,,hippuryl-L-lysine,serum,.,Fourteen,cystic,fibrosis,patients,steatorrhea,therefore,minimal,pancreatic,dysfunction,.,Patients,cystic,fibrosis,controls,comparable,age,.,Serum,carboxypeptidase,B-like,activity,significantly,decreased,cystic,fibrosis,patients,including,cystic,fibrosis,patients,without,steatorrhea,.,Significantly,low,values,found,male,female,cystic,fibrosis,patients,compared,controls,similar,sex,.,Although,values,unaffected,age,control,population,,,values,older,patients,cystic,fibrosis,significantly,lower,values,younger,patients,.,correlation,obtained,serum,carboxypeptidase,B-like,activity,pulmonary,hepatic,function,.,Serum,carboxypeptidase,B-like,activity,therefore,falls,progression,disease,may,limit,ability,degrade,circulating,peptides,older,patients,cystic,fibrosis,.,Deficient,serum,carboxypeptidase,B-like,activity,less,likely,,,however,,,factor,development,early,manifestations,disease,.
Documento 65,false-positive,111In-labeled,leukocyte,scan,obtained,girl,cystic,fibrosis,infection,.,focal,accumulation,111In,activity,abdomen,marked,pulmonary,uptake,.,Surgical,exploration,postmortem,examination,revealed,abdominal,abnormality,.,abnormal,activity,apparently,due,swallowed,sputum,contained,labeled,leukocytes,.,Broader,clinical,implications,discussed,.
Documento 66,1,.,mucus,glycoproteins,meconium,normal,infants,infants,cystic,fibrosis,meconium,ileus,studied,.,2,.,Whereas,normal,meconium,contained,50,%,protein-bound,carbohydrate,,,meconium,cystic,fibrosis,contained,10,%,.,3,.,Glycopolypeptides,prepared,mucus,glycoproteins,.,oligosaccharide,units,material,released,fractionated,.,fractions,ranged,widely,size,composition,.,4,.,fractions,cystic,fibrosis,specimens,significantly,higher,content,fucose,normal,specimens,.
Documento 67,28,patients,cystic,fibrosis,aged,5,--,24,years,values,maximum,expiratory,flow,rates,(,Vmax,),lower,volume,levels,assessed,,,well,``,specific,'',conductance,respiratory,pathways,(,Gaw/TGV,),,,vital,capacity,(,VC,),,,total,lung,capacity,(,TLC,),,,residual,volume,(,RV,),,,functional,residual,capacity,(,FRC,),,,RV/TLC,FRC/TLC,ratios,one-second,forced,expiration,vital,capacity,(,FEV1,),evaluate,obstruction,respiratory,pathways,.,markedly,frequently,abnormal,values,Vmax,,,RV,RV/TLC,ratio,.,findings,revealed,almost,patients,CF,already,initial,examination,obstruction,peripheral,respiratory,pathways,hyperinflation,lungs,.,repeated,measurement,values,lung,function,15,patients,cystic,fibrosis,period,1,--,5,years,patients,increased,height,10,cm,average,,,values,deteriorate,average,.,,,however,,,individual,variability,investigated,values,period,.,comprehensive,treatment,provided,country,prevented,patients,CF,deterioration,obstruction,respiratory,pathways,period,investigation,.
Documento 68,Protease,activity,plasma,assayed,using,4-,methylumbelliferylguanidinobenzoate,.,assay,modified,carrying,reaction,presence,absence,benzamidine,,,competitive,inhibitor,trypsin-like,proteases,.,parameters,assay,described,detail,.,Using,assay,,,earlier,demonstration,deficiency,protease,activity,plasma,patients,cystic,fibrosis,confirmed,.,activity,,,corrected,nonspecific,hydrolysis,4-,methylumbelliferylguanidinobenzoate,benzamidine,,,expressed,nanomoles,4-methylumbelliferone,released,per,milliliter,plasma,.,standard,conditions,,,activity,plasma,activated,chloroform-ellagic,acid,127.2,+/-,23.1,7,controls,,,70.4,+/-,11.7,11,obligate,heterozygotes,,,48.7,+/-,16.6,12,patients,cystic,fibrosis,.,Identical,results,obtained,unactivated,plasma,used,.,data,demonstrate,judicious,use,specific,inhibitors,benzamidine,might,useful,assaying,low,levels,protease,activity,crude,systems,.
Documento 69,nine,cystic,fibrosis,patients,chronic,bronchopulmonary,infection,severely,damaged,lungs,invaded,Pseudomonas,aeruginosa,,,eleven,courses,prolonged,tobramycin,treatment,(,5,mg/kg/day,),four,16,weeks,administered,.,Pulmonary,symptoms,improved,better,quality,life,achieved,one,patient,.,Objective,parameters,(,chest,X-ray,,,pulmonary,function,tests,),changed,lesser,extent,.,one,patient,Pseudomonas,eradicated,sputum,reappeared,discontinuation,therapy,.,rest,patients,Pseudomonas,significantly,suppressed,replaced,pathogens,.,Four,patients,showed,rises,antibody,titres,Candida,two,Aspergillus,fumigatus,.,nephrotoxic,side,effects,observed,,,vestibular,function,reversibly,impaired,one,patient,without,corresponding,clinical,symptoms,.,bacterial,resistance,tobramycin,observed,therapy,.
Documento 70,Clinical,radiological,findings,,,quantified,special,scores,,,36,patients,cystic,fibrosis,compared,lung,function,measurements,,,including,ratio,RV/TLC,FEV/VC,arterial,blood,gases,rest,exercise,.,Although,respiratory,function,tests,found,correlate,well,pulmonary,finding,score,chest,radiographic,score,,,distinction,three,severity,groups,possible,vector,calculation,blood,gases,PaO2-PaCO2-diagram,,,rest,exercise,.,Thus,,,measurements,pO2,pCO2,rest,exercise,appear,helpful,adjuvant,routine,spirometry,individual,appraisal,degree,lung,involvement,,,performance,care,level,.
Documento 71,Quantitative,functional,assessments,made,classical,alternative,pathways,complement,activation,sera,23,patients,cystic,fibrosis,.,classical,pathway,functioned,similarly,patients,controls,measured,CH50,titre,.,Alternative,pathway,function,,,initiated,patient,sera,incubation,inulin,,,equal,controls,determined,cleavage,Factor,B,C3,,,consumption,terminal,components,.,Factor,B,,,however,,,readily,activated,patient,control,sera,.,rapid,alteration,Factor,B,lead,accelerated,extensive,activation,terminal,complement,components,via,alternative,pathway,assessed,C3,cleavage,consumption,terminal,components,.,Thus,,,complement,deficiency,found,.,importance,easily,activated,Factor,B,undefined,.
Documento 72,Using,radioimmunoassay,,,immunoreactive,SP,(,iSP,),measured,plasma,162,hospital,patients,various,disorders,plasma,67,pregnant,women,.,pregnancy,,,iSP,undetectable,40,%,women,compared,12,%,hospital,patients,.,mean,iSP,plasma,level,pregnancy,37.8,+/-,4.6,(,SEM,),compared,77.1,+/-,4.9,(,SEM,),pg/ml,hospital,patients,.,results,support,earlier,observations,based,bioassay,,,suggesting,blood,pregnant,women,contains,higher,concentrations,SP-inactivating,factor,.,hospital,patients,,,elevated,levels,iSP,found,patients,chronic,leukaemia,,,one,patient,basaloid,carcinoma,anus,,,one,patient,toxic,liver,damage,pancreatic,insufficiency,.,correlation,found,thyroid,function,iSP,plasma,levels,.,ISP,plasma,levels,various,gastrointestinal,disorders,similar,found,normal,subjects,.
Documento 73,short,circuit,current,rat,jejunum,bioassay,,,first,employed,attempt,discern,cystic,fibrosis,(,CF,),serum,``,factor,,,'',evaluated,using,sera,patients,pancreatic,disease,.,data,suggest,pancreatic,diseases,,,specifically,genetic,diabetes,alcoholic,pancreatitis,,,also,present,serum,'',factor,'',(,``,factors,'',),reduce,short,circuit,current,rat,jejunum,,,effect,similar,CF,serum,'',factor,.,'',large,number,sera,presumed,normal,subjects,also,exhibited,significant,reduction,short,circuit,current,;,(,false,positives,),represent,yet,defined,mechanism,,,however,,,decrease,likelihood,observed,effect,merely,due,pancreatic,destruction,.,Detailed,procedure,equipment,specifications,bioassay,system,included,.
Documento 74,vitro,lymphocyte,responses,Pseudomonas,aeruginosa,found,impaired,cystic,fibrosis,patients,advanced,clinical,disease,.,responses,Klebsiella,pneumoniae,,,Serratia,marcescens,,,Proteus,mirabilis,studied,similar,group,cystic,fibrosis,patients,normal,individuals,.,Cystic,fibrosis,patients,found,unresponsive,pseudomonas,also,unresponsive,klebsiella,,,serratia,,,proteus,.,Responsiveness,Staphylococcus,aureus,impaired,cystic,fibrosis,patients,.,postulate,vitro,lymphocyte,responses,several,gram-,negative,bacteria,require,function,lymphocyte,subpopulation,may,impaired,cystic,fibrosis,patients,.
Documento 75,bacteriological,effect,chemotherapy,mucoid,strains,Pseudominas,aeruginosa,lower,respiratory,tract,patients,cystic,fibrosis,reported,.,comparison,effect,high,doses,tobramycin,(,10,mg/kg/24,h,),given,alone,combination,carbenicillin,showed,significant,difference,favour,combination,therapy,.,74.5,%,initially,successful,courses,patients,recolonized,within,one,month,.,Fifty-three,patients,examined,audiometric,vestibular,tests,.,one,patient,possible,register,transient,,,high,tone,hearing,impairment,8000,Hz,bilaterally,,,might,attributed,tobramycin,treatment,.,concluded,high,dose,tobramycin,treatment,children,adolescents,normal,kidney,function,implies,minimal,clinical,risk,adverse,ototoxic,effects,,,even,repeated,courses,treatment,.,nephrotoxic,side-effects,found,material,.
Documento 76,Fifty-three,patients,cystic,fibrosis,treated,large,doses,tobramycin,sulphate,,,10,mg/kg/24,h.,Patients,received,average,3.2,courses,,,lasting,10,14,days,.,patients,examined,audiometric,vestibular,tests,,,one,patient,,,10-year-old,girl,,,found,transient,high,tone,loss,8000,Hz,bilaterally,might,attributed,tobramycin,treatment,.,patients,normal,kidney,function,.,High,dose,tobramycin,treatment,children,normal,kidney,function,gives,minimal,clinical,risks,adverse,ototoxic,effects,,,even,repeated,courses,treatment,.
Documento 77,one,thousand,patients,acute,chronic,chest,infections,treated,combination,trimethoprim,sulphamethoxazole,.,patients,may,divided,four,groups,results,summarised,presentation,.,Much,work,published,elsewhere,.
Documento 78,Three,main,reasons,advanced,degree,ignorance,confusion,surrounding,epidemiologic,measures,incidence,prevalence,Cystic,Fibrosis,.,(,CF,),Relatively,recent,recognition,CF,specific,disease,entity,.,Wide,range,clinical,manifestations,,,presentation,multisystem,disease,,,great,natural,variation,severity,involvement,various,organs,.,Past,difficulty,establishing,diagnosis,based,sound,laboratory,evidence,,,largely,due,lack,screening,test,gained,wide,acceptance,among,diagnosticians,,,inaccuracies,performance,interpretation,sweat,test,.,addition,factors,,,number,methodological,deficiencies,questionable,assumptions,several,papers,reviewed,.,may,noteworthy,two,sets,authors,whose,research,design,closely,matched,aimed,providing,multiple,ascertainment,cases,cross-checks,validity,,,arrived,nearly,estimated,incidence,particular,disorder,(,1/3700,1/3800,respectively,),.,issue,selection,diagnostic,criteria,one,important,implications,epidemiologic,studies,cystic,fibrosis,.,Particularly,disease,like,CF,,,spectrum,clinical,manifestations,severity,involvement,broad,,,estimates,incidence,vary,according,criteria,cases,ascertained,included,.,greater,degree,uniformity,standards,employed,previous,studies,necessary,comparisons,meaningfully,made,.,good,grounds,regarding,estimates,CF,incidence,minimum,confirmed,figures,,,particularly,research,design,ensures,multiple,ascertainments,case,identifiable,.,Higher,estimates,made,several,sources,error,(,respondent,bias,,,generalization,hospital,data,wider,population,,,multiple,ascertainments,patient,),recognised,.
Documento 79,impact,death,cystic,fibrosis,child,subsequent,family,function,evaluated,retrospective,study,16,families,.,findings,similar,reported,another,model,fatal,childhood,illness,,,leukemia,,,high,incidence,emotional,medical,problems,parents,.,unexpectedly,high,incidence,(,7/16,),incomplete,mourning,,,i.e.,,,maintenance,child,'s,room,shrine,weekly,grave,visit,six,months,.,Siblings,less,difficulty,adjusting,loss,reported,siblings,leukemic,children,.,suggested,prolonged,course,disease,hopeless,prognosis,prepares,family,child,'s,death,also,retards,mourning,process,.,family,may,need,counseling,ensure,mourning,completed,.
Documento 80,Factors,influence,hemoglobin,(,Hb,),Aic,synthesis,intact,erythrocytes,studied,vitro,.,incubation,cells,lysed,,,hemoglobins,separated,isoelectric,focusing,polyacrylamide,slab,gels,quantitated,microdensitometry,.,HbAic,increased,time,,,glucose,concentrations,(,5-500,mM,),incubation,temperature,(,4,degrees-37,degrees,C,),.,Low,temperatures,allowed,prolonged,incubations,minimal,hemolysis,.,4,degrees,C,HbAic,increased,linearly,time,6,wk,;,incubation,highest,glucose,concentration,,,HbAic,comprised,50,%,total,hemoglobin,.,Insulin,(,1,0.1,mU/ml,),affect,HbAic,synthesis,vitro,.,addition,glucose,,,galactose,mannose,,,fructose,,,served,precursors,HbAic,.,good,substrate,hexokinase,(,2-deoxy-glucose,),poor,hexokinase,substrate,(,3-O-methyl-glucose,),,,better,precursors,HbAic,synthesis,glucose,,,suggesting,enzymatic,phosphorylation,glucose,required,HbAic,synthesis,.,Autoradiography,erythrocyte,incubation,32P-phosphate,showed,incorporation,radioactivity,HbAia1,HbAia2,,,HbAib,,,Aic,,,A.,Acetylated,HbA,,,generated,incubation,acetylsalicylate,,,migrated,anodal,HbAic,clearly,separated,.,Erythrocytes,patients,insulinopenic,diabetes,mellitus,synthesized,HbAic,rate,controls,incubated,identical,glucose,concentrations,.,Likewise,,,rate,HbAic,synthesis,erythrocytes,patients,cystic,fibrosis,congenital,spherocytosis,paralleled,controls,.,erythrocytes,cord,blood,HbC,sickle,cell,anemia,patients,incubated,elevated,concentrations,glucose,,,fetal,Hb,,,HbC,,,sickle,Hb,decreased,whereas,hemoglobins,focusing,isoelectric,points,near,expected,corresponding,glycosylated,derivatives,appeared,proportionately,increased,amounts,.
Documento 81,phenotypic,characterization,Pseudomonas,aeruginosa,single,sputum,samples,21,typical,cystic,fibrosis,patients,indicated,high,frequency,heterogeneity,among,isolates,basis,differences,antibiotic,resistance,,,colony,morphology,,,pigmentation,,,serotype,.,Two,isolates,different,stable,susceptibilities,carnecillin,,,gentamycin,,,streptomycin,,,tetracycline,,,chloramphenicol,,,sulfamethoxazole,plus,trimethoprim,detected,38,%,sputa,.,Differences,generally,independent,mucoid,state,strain,.,O-,antigen,group,determination,Difco,typing,set,showed,two,serologically,distinct,strains,present,10/21,sputum,specimens,.,Nonmucoid,derivatives,mucoid,isolates,almost,always,retained,antibiotic,susceptibilities,serotype,parent,strain,.,data,suggest,cystic,fibrosis,patients,may,cocolonized/coinfected,difference,strains,P.,aeruginosa,frequently,generally,believed,.,Alternatively,,,phenotypically,distinct,strains,single,patient,might,arise,phenotypic,dissociants,single,infecting,strain,.,frequency,multiplicity,phenotypically,distinct,P.,aeruginosa,isolates,obtained,cystic,fibrosis,patients,,,important,select,multiple,isolates,sputum,cultures,antimicrobial,susceptibility,testing,assess,adequately,susceptibility,organism,antibiotic,therapy,cystic,fibrosis,.,recommend,several,colonies,distinguishable,colony,type,P.,aeruginosa,pooled,antibiogram,.
Documento 82,dietary,problems,associated,care,chronically,sick,children,considered,two,broad,headings,.,First,,,problems,children,diet,essential,part,treatment,chronic,disorder,;,second,nutritional,complications,may,occur,children,chronic,diseases,diet,specific,role,treatment,,,thus,often,neglected,considered,later,stage,management,.,Many,problems,course,common,situations,.,paper,review,briefly,difficulties,,,illustrating,specific,examples,;,attempt,made,describe,discuss,treatment,particular,disorder,.
Documento 83,Acute,pseudomonas,infections,require,treatment,antibiotics,producing,bactericidal,effect,.,useful,gentamicin,,,tobramycin,,,sisomicin,polymyxin,B,.,resistant,strains,,,amikacin,indicated,addition,.,Carbenicillin,,,ticarcillin,,,carfenicillin,azocillin,never,given,alone,combination,preparations,.,drugs,,,chloramphenicol,,,tetracycline,streptomycin,,,though,effective,vitro,,,avoided,.,Chemotherapy,may,complemented,passive,immunization,either,hyperimmune,specific,gama,globulin,hyperimmune,plasma,.,programmatic,item,combined,treatment,active,immunization,,,especially,toxoid,vaccine,.,Chronic,processes,,,perhaps,exception,urinary,infections,,,suitable,antibiotic,therapy,.,reason,effective,polyvalent,vaccines,developed,appropriate,strains,.,certain,infections,caused,mucous,strains,(,frequently,encountered,cystic,fibrosis,),vaccine,prepared,strains,,,since,distinct,functional,antigenic,characteristics,.
Documento 84,Although,N-acetyl-L-cysteine,(,Mucomyst,),effective,mycolytic,,,numerous,investigations,failed,demonstrate,consistent,improvement,pulmonary,mechanics,following,use,.,order,determine,whether,beneficial,mucolytic,activity,might,counterbalanced,deleterious,direct,effect,cilia,,,studied,effect,activity,ciliated,epithelium,ferret,tracheal,organ,culture,system,.,N-acetyl-L-cysteine,consistently,caused,progressive,time-dependent,ciliostasis,concentrations,clinically,employed,,,complete,ciliary,paralysis,within,8,hr,.,effect,partially,reversed,removal,drug,.,Control,preparations,retained,full,ciliary,activity,3,12,weeks,.,order,determine,active,site,N-acetyl-L-,cysteine,molecule,,,investigated,ciliostatic,effects,five,chemical,analogs,.,Isomolar,N-acetyl-L-alanine,ciliostatic,,,indicating,necessity,sulfhydryl,group,activity,.,Ciliostasis,independent,isomeric,structure,,,acetylation,,,chain,length,,,evidenced,similar,ciliostatic,effects,L-cysteine,,,D-cysteine,,,2-mercaptoethylamine,,,N-acetyl-L-homocysteine,.,conclude,N-acetyl-L-cysteine,induces,partially,reversible,ciliostasis,tracheal,epithelium,via,sulfhydryl,group,;,prolonged,use,drug,may,impair,mucociliary,clearance,.
Documento 85,retrospective,study,cystic,fibrosis,Northern,Ireland,1961,1971,,,incidence,1,1857,livebirths,,,comparable,figures,Great,Britain,Republic,Ireland,.
Documento 86,Palpable,purpura,noted,occur,late,course,patients,cystic,fibrosis,.,Skin,biopsy,specimens,showed,necrotizing,venulitis,characterized,perivenular,infiltrate,composed,neutrophilic,leukocytes,,,fibrin,,,hypogranulated,mast,cells,,,endothelial,cell,necrosis,.,Circulating,immune,complexes,detected,.,Recurrent,pulmonary,infections,chronic,administration,therapeutic,agents,provide,sources,potential,antigens,.
Documento 87,Ten,patients,(,6,27,years,age,),severe,pancreatic,exocrine,insufficiency,due,cystic,fibrosis,studied,determine,whether,cimetidine,would,improve,dietary,fat,nitrogen,absorption,.,constant,diet,consumed,oral,pancreatic,enzymes,administered,,,addition,cimetidine,(,150,200,mg,taken,orally,one-half,hour,meals,),signficantly,reduced,fecal,fat,excretion,25.3,+/-,2.9,17.3,+/-,2.1,gm/24,hours,fecal,nitrogen,excretion,4.5,+/-,0.6,3.4,+/-,0.5,gm/24,hours,(,P,less,0.05,),.,Lower,doses,cimetidine,resulted,less,significant,reductions,steatorrhea,azotorrhea,.,Cimetidine,may,useful,adjunct,oral,pancreatic,enzyme,therapy,patients,cystic,fibrosis,continue,steatorrhea,azotorrhea,enzyme,therapy,alone,.
Documento 88,prominent,role,infection,clinical,course,cystic,fibrosis,led,considerable,investigation,possible,immune,deficiency,patients,.,Leukotaxis,circulating,phagocytic,cells,ability,generate,chemotactic,factors,important,host,defenses,bacterial,invasion,.,properties,investigated,patients,clinically,stable,cystic,fibrosis,determine,possess,dysfunctional,inflammatory,responses,would,predispose,severe,infection,.
Documento 89,Severe,bronchial,hemorrhage,13,patients,cystic,fibrosis,treated,catheter,embolization,bronchial,arteries,.,Indications,either,excessive,bleeding,persisting,several,days,,,bleeding,serious,enough,interfere,pulmonary,drainage,recurring,weeks,months,.,follow-up,ranging,one,30,months,,,cessation,major,bleeding,achieved,12,13,patients,(,93,%,),,,although,5,13,patients,(,40,%,),recurrence,minor,hemoptysis,.,neurologic,major,complications,encountered,.,However,,,potential,risks,approach,present,limited,patients,life-threatening,bleeding,carried,experienced,angiographers,.
Documento 90,Vitamin,mineral,metabolism,studied,21,adolescents,young,adults,cystic,fibrosis,results,compared,21,matched,controls,.,CF,patients,maintained,standard,multivitamin,supplements,combination,pancreatic,enzyme,replacement,.,Despite,supplementation,,,relative,control,subjects,CF,patients,36,%,reduction,serum,25-,hydroxyvitamin,concentration,,,slight,significant,reduction,serum,calcium,concentration,,,evidence,calcium,malabsorption,secondary,hyperparathyroidism,,,14,%,decrease,bone,mass,measured,photon,absorption,technique,.,Currently,accepted,modes,pancreatic,enzyme,replacement,vitamin,supplementation,often,inadequate,maintain,normal,mineral,homeostasis,CF,patients,;,additional,measurements,may,required,reduce,risk,clinically,significant,osteopenia,concomitant,prolonged,survival,CF,.
Documento 91,cardiac,function,21,patients,cystic,fibrosis,studied,using,radionuclides,M-mode,echocardiography,.,patients,(,mean,age,13.2,years,,,range,4,27,),wide,range,clinical,pulmonary,function,abnormalities,(,mean,Shwachman-Kulczycki,score,62.1,),.,Decreased,right,ventricular,ejection,fraction,found,13,18,patients,(,72,%,),;,additional,four,patients,abnormal,septal,motion,ECHO,.,Left,ventricular,ejection,fraction,abnormal,rest,four,patients,(,19,%,),;,additional,four,patients,borderline,low,LVEF,.,LV,pre-ejection,period,ejection,time,ratio,increased,significantly,(,i.e.,,,worsening,LV,performance,),deterioration,S-K,score,,,chest,radiograph,score,,,forced,expiratory,volume,1,second,.,Three,eight,patients,normal,LVEF,rest,abnormal,response,supine,bicycle,exercise,:,LVEF,fell,two,patients,unchanged,one,.,Thus,evidence,LV,dysfunction,observed,seven,21,(,33,%,),patients,;,four,rest,three,exercise,.
Documento 92,effects,oral,administration,cephalexin,evaluated,double-blind,,,placebo-controlled,,,crossover,study,17,patients,mild,moderate,pulmonary,disease,due,cystic,fibrosis,.,two,years,,,four-month,periods,cephalexin,alternated,four-month,placebo,periods,.,Thus,,,patients,served,control,subjects,.,Fungal,vulvovaginitis,occurred,two,patients,cephalexin,therapy,.,2,years,study,,,rate,colonization,mucoid,strains,Pseudomonas,aeruginosa,increased,disease,severity,deteriorated,patients,initially,colonized,P.,aeruginosa,.,Short-term,courses,sputum,culture-specific,antibiotics,improved,course,patients,mild,moderate,pulmonary,disease,due,cystic,fibrosis,.,Treatment,cephalexin,decreased,frequency,respiratory,illnesses,,,respiratory,illnesses,requiring,antibiotics,,,hospitalizations,respiratory,illnesses,patients,initially,colonized,Staphylococcus,aureus,and/or,Haemophilus,influenzae,,,also,reduced,colonization,organisms,.,Improved,weight,gain,16,17,patients,associated,periods,cephalexin,therapy,.,Pulmonary,function,tests,remained,stable,improved,10,14,patients,.,Disease,severity,improved,patients,colonized,P.,aeruginosa,.
Documento 93,Sickle,cell,anemia,cystic,fibrosis,frequent,lethal,inherited,diseases,black,white,population,,,respectively,.,occurrence,diseases,individual,reported,literature,.,report,presents,two,patients,poses,questions,concerning,possible,clinical,implications,simultaneous,occurrence,diseases,.
Documento 94,Cystic,fibrosis,specific,disease,entity,known,associated,malnutrition,almost,half,century,.,importance,malnutrition,disease,process,remains,unknown,,,much,information,specific,nutritional,deficiencies,CF,.,Supplements,children,CF,include,extra,energy,fat,carbohydrate,,,form,linoleic,acid,absorbed,,,hydrolyzed,protein,,,fat-soluble,vitamins,vitamins,E,water,emulsion,,,vitamin,B12,,,probably,B,vitamins,vitamin,C,,,trace,minerals,.,Routine,measurements,nutritional,status,,,particularly,children,growth,failure,,,made,regular,intervals,include,three-day,diet,record,simultaneous,72-hour,stool,fat,determination,.,fat,malabsorption,controlled,pancreatic,enzymes,,,use,antacids,cimetidine,considered,.,true,role,nutrition,patients,CF,known,appropriate,studies,completed,.
Documento 95,Patients,cystic,fibrosis,fat,malabsorption,,,providing,experimental,model,evaluation,hypothesis,low-fat,intake,may,prevent,atherosclerosis,.,studied,frequency,extent,aortic,precursor,lesions,(,fatty,streaks,,,early,fibromusculoelastic,lesions,,,late,fibromusculoelastic,lesions,),found,autopsy,disease,well,patients,debilitating,disorders,apparent,impairment,fat,absorption,.,Fatty,streaks,less,common,cystic,fibrosis,group,,,late,fibromusculoelastic,lesions,.,significant,difference,frequency,,,length,,,thickness,early,fibromusculoelastic,lesions,.,findings,suggest,fat,may,responsible,progression,initiation,fibromusculoelastic,precursor,lesions,,,support,concept,early,restriction,dietary,fat,may,prevent,,,delay,,,otherwise,modify,atherosclerosis,adult,.
Documento 96,Brain,abscess,recently,considered,complication,cystic,fibrosis,.,Three,patients,reported,fourth,cited,literature,.,patients,young,adults,advanced,pulmonary,disease,.,bacteria,involved,mouth,organisms,found,sputum,culture,one,patients,.,Resistance,present,previously,given,antibiotics,.,patients,cystic,fibrosis,survive,adulthood,,,risk,developing,brain,abscess,appears,increase,.
Documento 97,14,yr,1965,1978,,,49,infants,presented,shortly,birth,intestinal,obstruction,due,impacted,meconium,.,Three,patients,fibrocystic,disease,.,Eight,patients,cured,Gastrografin,enema,.,18,patients,complications,included,associated,atresia,,,volvulus,,,and/or,peritonitis,.,Various,operations,done,including,resection,either,primary,anastomosis,enterostomy,varieties,foregoing,.,Twenty-three,babies,simple,uncomplicated,form,meconium,ileus,.,Eleven,underwent,resection,six,patients,died,.,Twelve,patients,treated,laparotomy,,,ileotomy,purse-string,suture,prolonged,irrigations,using,acetylcysteine,.,group,one,succumbed,.,latter,course,management,recommended,patients,simple,uncomplicated,meconium,ileus,involves,resection,,,enterostomy,,,primary,anastomosis,.
Documento 98,total,active,transport,Cl,ions,across,frog,'s,gastric,mucosa,considered,:,net,Cl-,flux,(,serosa,mucosa,),=,H+,+,SSC,(,short-circuit,current,),,,terms,expressed,micromole,cm-2,hr-1,.,net,chloride,flux,(,Hogben,,,1955,;,Durbin,Heinz,,,1958,),may,divided,two,fractions,:,acidic,one,equivalent,acid,secreted,electromotive,one,accounts,gastric,electromotive,force,.,changes,SCC,accordingly,used,partial,index,activity,chloride,pump,.,Experiments,designed,investigate,effects,histamine,,,metiamide,(,H2,receptor,antagonist,),,,cystic,fibrosis,(,CF,),non-CF,plasma,parameters,using,frog,'s,isolated,gastric,mucosa,.,SCC,resistance,mucosal,preparation,measured,means,automatic,SCC,apparatus,(,de,Jesus,,,1977,),.,H,ion,secretion,measured,pH,meter,.,Results,obtained,(,expressed,mean,change,(,delta,),plus,minus,S.E,.,mean,),histamine,(,10-4,),(,n,=,10,),show,initial,increase,SCC,36.94,plus,minus,2.95,microA,cm-2,parallel,small,increase,H+,output,0.045,plus,minus,0.003,micromole,cm-2,hr-1,.,initial,increase,SCC,followed,drop,steady-state,level,23.62,plus,minus,2.23,microA,cm-2,also,large,increase,H+,secretion,2.26,plus,minus,0.22,micromole,cm-2,hr-1,.,results,support,work,Rehm,(,1961,),histamine,effect,first,Cl-,pump,H+,secretion,.,Metiamide,(,10-4,),(,n,=,12,),caused,drop,SCC,20.16,plus,minus,2.32,microA,cm-2,also,reduced,acid,secretion,2.21,plus,minus,0.14,micromole,cm-2,hr-1,,,thus,suggesting,effect,Cl-,pump,well,H+,secretion,.,Significant,differences,shown,(,P,<,0.001,),CF,non-CF,plasma,results,.,CF,plasma,(,n,=,8,),increased,SCC,17.25,plus,minus,2.94,microA,cm-2,H+,secretion,2.38,plus,minus,0.43,micromole,cm-2,hr-1,.,Non-CF,plasma,caused,slight,increase,SCC,5.17,plus,minus,1.1,microA,cm-2,little,effect,H+,secretion,,,0.34,plus,minus,0.01,micromole,cm-2,hr-1,(,n,=,8,),.,effect,CF,plasma,Cl-,H+,mechanism,interest,since,cystic,fibrosis,abnormal,increase,Cl-,Na+,sweat,patients,(,di,Sant,Agnese,,,Darling,,,Perera,,,1953,),.
Documento 99,Schulz,(,1969,),showed,raised,Na,concentration,sweat,children,suffering,cystic,fibrosis,due,defect,Na,reabsorption,duct,epithelium,,,somewhat,surprisingly,transepithelial,potential,difference,(,p.d,.,),normal,controls,.,Na,transport,also,reduced,chronically,ligated,salivary,duct,rabbit,submandibular,gland,(,Fraser,Smaje,,,1978,),,,p.d,.,unaffected,,,ligated,gland,may,useful,model,aspect,cystic,fibrosis,.,would,like,report,similarity,cystic,fibrosis,;,duct,ligation,leads,goblet,cell,hyperplasia,also,occurs,salivary,glands,cystic,fibrosis,(,Lev,Spicer,,,1965,),.,Sections,salivary,duct,6,microm,thick,taken,60,microm,intervals,ducts,ligated,1,5,weeks,contralateral,controls,following,fixation,immersion,.,Ligation,resulted,increase,luminal,diameter,distension,previously,convoluted,epithelium,,,significant,change,epithelial,surface,area,.,number,cell,layers,appeared,increased,however,proliferation,goblet,cells,.,mucus,cells,stained,alcian,blue,pH,1,indicating,presence,sulphomucin,.,mean,goblet,cell,density,rose,7.62,plus,minus,4.73,mm-2,(,mean,plus,minus,S.E,.,mean,,,n,=,6,),controls,114,plus,minus,49.6,ligated,ducts,.,transepithelial,Na,flux,ducts,reduced,10.1,plus,minus,0.79,n-mole,cm-2,sec-1,1.6,plus,minus,0.84,p.d,.,remained,-22,mV,,,similar,results,previously,reported,.,significant,correlation,degree,diminution,Na,transport,density,goblet,cells,positive,correlation,(,r,=,0.90,),number,goblet,cells,control,contralateral,ligated,ducts,.
Documento 100,Immunoreactive,serum,trypsin,measured,double,antibody,radioimmunoassay,normal,subjects,patients,various,diseases,pancreas,.,normal,range,115-350,ng/ml,geometric,mean,212,ng/ml,.,trypsin,found,serum,total,duodenopancreatectomy,,,75,%,patients,cystic,fibrosis,patients,pancreas,carcinoma,chronic,pancreatitis,.,Reduced,serum,trypsin,levels,10,100,ng/ml,measured,remaining,25,%,cystic,fibrosis,one,third,patients,chronic,pancreatitis,.,Serum,trypsin,increased,700-17,000,ng/ml,patients,acute,pancreatitis,acute,phase,chronic,pancreatitis,.,Absent,reduced,serum,trypsin,reliable,indicator,total,partial,exocrine,pancreatic,insufficiency,whereas,considerably,increased,serum,trypsin,concentration,indicate,acute,pancreatitis,.
Documento 101,Nineteen,nasal,polyps,13,patients,examined,histologically,.,Nine,polyps,seven,cystic,fibrosis,(,CF,),patients,could,positively,identified,triad,observations,:,delicate,,,barely,visible,basement,membrane,surface,epithelium,without,submucosal,hyalinization,,,lack,extensive,infiltration,eosinophils,(,Giemsa,stains,),,,preponderance,acid,mucin,glands,cysts,polyp,surface,mucous,blanket,(,Alcian,Blue-periodic,acid-,Schiff,stains,),.,Two,polyps,two,patients,CF,atopy,showed,characteristic,findings,CF,without,modification,.,Eight,polyps,four,atopic,patients,without,CF,identified,reverse,triad,changes,:,extensive,thickening,epithelial,basement,membrane,extension,submucosa,irregular,hyaline,membrane,,,high,stromal,eosinophil,count,,,mainly,neutral,mucin,mucous,glands,,,cysts,,,mucous,blanket,.,Hyperplastic,mucous,glands,,,mucous,cysts,variable,sizes,,,focal,metaplasia,surface,epithelium,,,acid,mucin,goblet,cells,considered,nonspecific,lesions,.
Documento 102,immunoreactive-trypsin,assay,uses,small,dried-blood,spots,(,diameter,1.25,mm,),therefore,suitable,incorporation,established,neonatal,screening,schemes,.,Blood,specimens,neonates,cystic,fibrosis,trypsin,levels,greater,control,subjects,,,thus,confirming,earlier,findings,.,Trypsin,levels,normal,several,older,patients,cystic,fibrosis,.
Documento 103,Serum-immunoreactive-trypsin,(,I.R.T,.,),measured,children,cystic,fibrosis,(,C.F,.,),variety,controls,.,first,months,life,C.F,.,children,raised,serum-I.R.T,.,dried,blood-spot,assay,I.R.T,.,established,potential,screening,test,C.F,.,newborn,.
Documento 104,Evidence,accumulating,indicates,basic,defect,cystic,fibrosis,interferes,formation,recognition,markers,hydrolytic,enzymes,.,result,hydrolases,leak,extracellular,space,display,abnormal,thermolabilities,.,heat,inactivation,plasma,alpha-mannosidase,41,degrees,C,plasma,phosphatase,36.5,degrees,C,,,enzymes,assayed,pH,5.4,,,possible,differentiate,normal,people,cystic,fibrosis,carriers,patients,.
Documento 105,Tritiated,thymidine,(,3H-TdR,),incorporation,DNA,fibroblasts,derived,subjects,cystic,fibrosis,(,CF,),controls,studied,scintillation,counting,autoradiography,.,3H-TdR,incorporation,24,hours,postseeding,significantly,less,(,p,<,0.005,),CF,strains,comparison,cells,controls,.,percentage,labeled,fibroblasts,significantly,difference,two,strains,(,p,>,0.1,),.,cell,cycle,time,duration,phase,studied,mitotic,selection,scintillation,counting,technique,.,difference,cell,cycle,time,CF,control,fibroblasts,,,however,,,duration,synthetic,phase,significantly,(,p,<,0.005,),longer,CF,subjects,.
Documento 106,Since,demonstrated,chronic,administration,reserpine,rats,produces,CF-like,alterations,,,studied,lung,resistance,bacterial,infections,animals,treated,reserpine,.,Mice,BALB/c,inbred,strain,injected,subcutaneously,different,doses,reserpine,7,days,;,,,submitted,infective,aerosol,containing,Staphylococcus,aureus,nebulization,chamber,.,pair,exposed,animals,,,individual,value,uncleared,bacteria,ratio,(,UBR,),4,hours,obtained,.,Reserpinized,animals,showed,significant,increase,UBR,values,compared,control,mice,(,p,<,0.05,p,<,0.01,depending,doses,),,,suggesting,impairment,lung,antibacterial,defenses,.,Although,pharmacological,doses,reserpine,produce,catecholamine,depletion,,,conclude,action,upon,nervous,system,cause,CF-like,response,detected,.,conclusion,,,observed,UBR,decrease,lends,support,concept,reserpine-,induced,CF,animal,model,.
Documento 107,Cystic,fibrosis,common,lethal,semi-lethal,genetic,disease,Caucasians,Central,European,origin,,,among,inherited,autosomal,recessive,trait,frequency,approximately,10,times,expected,recurrent,mutation,alone,.,decreased,sialic,acid,content,observed,cell,surface,glycoproteins,cystic,fibrosis,fibroblasts,numerous,soluble,glycoprotein,preparations,cystic,fibrosis,homozygotes,.,Sialic,acid,residues,cell,surface,glycoconjugates,play,essential,role,binding,infectivity,myxoviruses,paramyxoviruses,,,including,causing,pandemic,influenza,.,suggested,increased,resistance,viruses,conferred,similar,quantitatively,smaller,alterations,sialoglycoconjugate,structure,cystic,fibrosis,heterozygotes,may,provided,selective,advantage,maintain,high,frequency,cystic,fibrosis,gene,Caucasian,populations,.
Documento 108,pathogenesis,cystic,fibrosis,(,CF,),considered,lie,disturbance,behavior,secretions,,,particularly,mucins,,,exocrine,glands,,,proposed,alteration,surface,topography,(,form,,,number,distribution,microvilli,blebs,),epithelial,cells,lining,ducts,could,impair,distribution,leading,retention,mucus,leading,clinical,phenotype,.,Scanning,electronmicroscopy,human,epithelial,suspension,cultures,offers,opportunity,evaluate,role,plasmalemma,topography,CF,.
Documento 109,survival,320,patients,,,born,1958,cystic,fibrosis,managed,Departments,Thoracic,Medicine,Gastroenterology,,,Royal,Children,'s,Hospital,,,Melbourne,,,reviewed,.,Eighty,per,cent,patients,survived,11,years,age,,,64,%,18,years,.,patients,managed,1973,1977,,,91,%,survived,12,years,age,,,80,%,17,years,age,.,period,,,79,%,patients,survived,16,years,diagnosis,.,Forty-,four,per,cent,240,patients,currently,managed,significant,permanent,lung,disease,,,9,%,advanced,disease,.
Documento 110,Chest,physiotherapy,important,part,treatment,program,children,cystic,fibrosis,,,controlled,studies,effects,.,27,children,cystic,fibrosis,,,20,chronic,sputum,producers,7,non-sputum,producers,,,studied,hospital,serial,lung,function,tests,3,consecutive,days,.,1st,day,physiotherapy,performed,twice,;,2nd,day,physiotherapy,performed,;,3rd,day,two,periods,physiotherapy,preceded,inhaled,bronchodilator,(,Rimiterol,),.,Lung,function,tests,included,peak,flow,,,forced,vital,capacity,(,FVC,),,,forced,expiratory,volume,1,sec,(,FEV1.0,),residual,volume,total,lung,capacity,ratio,,,measured,beginning,day,similar,intervals,throughout,3,days,.,Sputum,volume,cough,frequency,noted,day,1,day,3,.,Physiotherapy,resulted,significant,improvement,peak,flow,sputum,producers,.,However,,,FVC,FEV1.0,,,improving,physiotherapy,,,also,improved,control,day,physiotherapy,performed,.,suggests,physiotherapy,may,effective,removing,sputum,central,large,airways,resultant,improvement,peak,flow,,,little,added,effect,peripheral,airways,,,whose,airflow,improves,day,normal,activity,.,significant,effect,shown,non-,sputum,producers,although,trend,towards,improvement,peak,flow,.,bronchodilator,physiotherapy,may,beneficial,patients,demonstrate,significant,reduction,airflow,obstruction,formal,testing,bronchodilator,response,,,may,lessen,beneficial,effects,physiotherapy,without,positive,response,.,study,illustrates,importance,examining,difference,methods,chest,physiotherapy,,,find,ways,improving,sputum,clearance,.
Documento 111,17,children,(,group,),cystic,fibrosis,(,CF,),effect,following,treatment,schedules,pulmonary,function,studied,random,order,4,consecutive,days,:,(,1,),clapping,postural,drainage,(,CP,),;,(,2,),CP,inhaling,aerosol,5,ml,20,%,N-acetylcysteine,Monaghan,ultrasonic,device,;,(,3,),2,addition,0.5,mg,isoprenaline,aerosol,;,(,4,),3,IPPB,device,added,nebulizer,.,Treatment,started,9.30,a.m.,lasted,1,h.,Pulmonary,function,measured,prior,30,min,treatment,(,9.00,11.00,a.m.,,,respectively,),.,8,children,(,group,B,),CF,(,severity,comparable,previous,group,),pulmonary,function,measured,9.00,11.00,a.m.,without,physiotherapy,.,following,pulmonary,function,measurements,included,evaluation,results,:,VC,,,FVC,,,FEV1,,,TLC,(,body,box,),,,TLC,(,helium,dilution,),,,TLCBb-TLCHe,,,RVBb,,,RVHe,,,maximal,expiratory,flows,60,%,TLBBb,,,25,%,FVC,,,maximal,midexpiratory,flow,,,airway,conductance,.,technique,determinations,carefully,controlled,initial,values,reproducible,children,.,group,B,,,mean,values,pulmonary,function,equal,9.00,11.00,a.m,.,group,none,treatment,schedules,caused,significant,improvement,mean,pulmonary,function,values,.,children,,,however,,,pulmonary,function,improved,,,others,deteriorated,.,significance,findings,discussed,.
Documento 112,Prone,immersion,physical,exercise,therapy,used,successfully,physical,rehabilitation,middle-aged,adults,moderate,severe,chronic,obstructive,pulmonary,disease,.,purpose,pilot,project,evaluate,effects,PIPE,therapy,children,cystic,fibrosis,.,Three,children,CF,,,two,boys,aged,6,14,years,one,girl,aged,15,years,,,voluntarily,participated,experimental,training,program,.,patients,performed,individualized,group,exercise,three,times,week,alternate,days,28,consecutive,weeks,intensity,approximately,75,percent,aerobic,capacity,.,Duration,exercise,gradually,increased,15,(,3,x,5,minutes,),60,(,3,x,20,minutes,),minutes,rest,period,exercise,constant,two,minutes,.,PIPE,training,resulted,increased,physical,work,capacity,maximal,oxygen,consumption,three,subjects,.,Curiously,,,changes,accompanied,training,bradycardia,.
Documento 113,Two,groups,investigators,independently,explored,role,vitamin,related,mineral,metabolism,patients,cystic,fibrosis,,,found,relatively,minor,changes,.
Documento 114,Serial,dilutions,pyridine,water,employed,measuring,olfactory,detection,thresholds,patients,.,Experimental,precautions,described,improve,precision,accuracy,method,.,Existing,data,sensitivities,hyposmic,patients,confirmed,,,sensitivities,normal,subjects,hyperosmic,patients,believed,substantially,overestimated,earlier,publications,.,Routine,clinical,applications,revised,pyridine,odor,threshold,test,discussed,.,author's,experience,,,average,cystic,fibrosis,patient,slightly,hyposmic,,,cases,pituitary,tumor,accompanied,100,000-fold,hyperosmia,.
Documento 115,annotated,catalog,clinical,pathologic,observations,adult,population,CF,presented,.,spectrum,disease,broad,,,diagnosis,usually,requires,demonstration,abnormalities,multiple,systems,.,Tissues,germ,layer,found,involved,CF,.,Correlation,clinical,pathologic,observations,suggests,manifestations,essentially,episodic,focal,.,population,,,characteristic,abnormalities,recognized,pathologist,focal,biliary,cirrhosis,,,distinctive,obstructive,lesions,male,genital,tract,,,prolonged,staphylococcal,pseudomonas,colonization,respiratory,secretions,,,obstructive,bronchopulmonary,disease,.,form,pancreatic,atrophy,usually,present,.
Documento 116,Several,genetic,diseases,described,affect,lung,,,usually,least,cases,,,pediatric,age,group,.,four,disorders,discussed,selected,wither,high,frequency,demonstration,variety,ways,genetic,factors,influence,disease,:,cystic,fibrosis,,,one,common,metabolic,disorders,inherited,autosomal,recessive,trait,;,immotile,cilia,syndrome,,,including,Kartagener's,syndrome,,,single,gene,disorders,involving,structural,abnormalities,cilia,;,asthma,,,common,disorder,children,genetic,component,;,alpha1-antitrypsin,deficiency,,,inherited,protein,deficiency,commonly,causing,obstructive,lung,disease,adults,occasionally,affecting,children,.
Documento 117,serum,proteins,bind,heparin,contribute,pH,5.57,``,heparin,binding,capacity,'',human,serum,glycoproteins,;,cystic,fibrosis,serum,found,27,%,higher,fucose,(,methylpentose,),content,,,27,%,lower,sialic,acid,content,,,31,%,lower,hexose,content,compared,heparin-,precipitated,serum,glycoproteins,normal,control,subjects,.,Hexosamine,content,heparin-precipitated,serum,glycoproteins,.,Results,preliminary,investigation,indicate,altered,carbohydrate,composition,serum,glycoproteins,may,affect,significantly,heparin,binding,capacity,.
Documento 118,Lung,lavage,samples,rats,treated,chronic,fashion,reserpine,mean,increases,133,,,170,,,120,%,total,protein,,,lipid,,,carbohydrate,contents,,,respectively,,,compared,untreated,control,animals,,,values,expressed,terms,body,weight,.,acute,single,ip,injection,beta-adrenergic,agent,isoproterenol,(,10,mg,),increased,glycoprotein,content,pulmonary,lavage,fluid,control,rats,approximately,15-19,%,,,9-10,%,reserpine,treated,rats,.,contrast,,,pilocarpine,(,10,mg,),,,administered,manner,,,caused,15,%,increase,total,protein,,,carbohydrate,,,lipid,content,lavage,samples,control,rats,increased,constituents,lavage,samples,reserpine,treated,rats,98,,,102,,,80,%,,,respectively,.,increased,total,carbohydrate,content,lavage,samples,treated,animals,associated,changes,percent,distribution,neutral,sugars,,,amino,sugars,,,sialic,acid,.,ratio,various,sugar,components,change,lavage,samples,control,reserpine,treated,rats,upon,stimulation,either,pilocarpine,isoproterenol,.,increased,total,lipid,content,fround,lavage,samples,treated,rats,probably,results,increase,phospholipids,.,decrease,phospholipid,content,occurred,lavage,samples,reserpine,treated,rats,upon,stimulation,,,opposite,observed,control,animals,.,Chronic,treatment,rats,reserpine,,,thus,,,appears,induce,enhanced,production,glycoproteins,airways,interfere,phospholipid,metabolism,lung,.,addition,,,drug,treatment,enhances,secretory,response,pilocarpine,comparison,responses,control,animals,.,enhanced,response,hypersecretion,glycoproteins,quantitative,one,seem,involve,alterations,ratios,distribution,various,sugar,components,.,disturbance,secretory,function,respiratory,tract,,,target,organ,prominently,involved,cystic,fibrosis,(,CF,),together,alterations,exocrine,glands,resemble,CF,patients,,,makes,reserpine,treated,rat,useful,model,study,possible,pathogenetic,mechanisms,CF,.,experimental,animal,model,CF,developed,chronic,administration,reserpine,rats,found,changes,protein,content,lung,lavage,samples,,,addition,morphologic,secretory,alterations,salivary,glands,pancreas,.,analysis,organic,composition,lung,lavage,samples,shows,protein,,,carbohydrate,,,lipid,contents,significantly,increased,chronic,reserpine,administration,response,stimulation,pilocarpine,enhanced,treated,animals,compared,untreated,control,rats,.,therefore,appears,chronic,reserpine,administration,causes,hypersecretion,glycoproteins,changes,lipid,metabolism,respiratory,tract,rat,,,conjunction,previous,findings,exocrine,glands,,,effects,lung,function,make,reserpine,treated,rat,useful,tool,study,pathologic,disturbance,seen,major,exocrine,glands,affected,CF,.
Documento 119,Children,cystic,fibrosis,excreted,elevated,urinary,levels,three,polyamines,--,putrescine,,,spermidine,,,spermine,.,Heterozygote,parents,excreted,intermediate,concentrations,polyamines,,,levels,significantly,different,levels,normal,controls,.,Patients,cystic,fibrosis,administered,tracer,amount,[,14C,],spermidine,excreted,11,--,13,%,radiolabel,within,72,hr,whereas,normal,controls,excreted,60,--,76,%,radiolabel,within,72,hr,.,Spermine,excretion,positively,correlated,increased,pathology,assessed,National,Institutes,Health,(,NIH,),clinical,score,,,whereas,urinary,putrescine,spermidine,levels,negatively,correlated,increased,pathology,.
Documento 120,retrograde,perfusion,assay,rat,parotid,gland,used,investigate,effects,salivary,secretions,control,reserpine-treated,rats,Na+,reabsorption,.,Results,demonstrated,submaxillary,saliva,treated,animals,caused,69,%,inhibition,Na+,reabsorption,,,accompanied,28,%,reduction,volume,saliva,secreted,,,22,%,reduction,flow,rate,.,contrast,,,submaxillary,saliva,control,rats,caused,6,%,inhibition,Na+,reabsorption,,,6,%,reduction,volume,,,5,%,reduction,flow,rate,.,Parotid,saliva,reserpine-treated,rats,also,inhibited,Na+,reabsorption,extent,39,%,caused,38,%,reduction,volume,33,%,reduction,flow,.,Parotid,saliva,control,rats,inhibited,Na+,reabsorption,extent,2.7,%,caused,4,--,6,%,reduction,salivary,volumes,flow,rates,.,inhibition,Na+,reabsorption,reduction,salivary,volume,flow,rates,caused,submaxillary,saliva,reserpine-treated,rats,either,abolished,significantly,reduced,saliva,previously,heated,100,degrees,C,,,frozen,,,thawed,kept,glass,tubes,4,degrees,C,24,hr,.,results,indicate,saliva,reserpine-treated,rats,comparable,effects,assay,system,saliva,cystic,fibrosis,(,CF,),patients,support,use,animal,model,disease,.
Documento 121,Sera,patients,cystic,fibrosis,pancreas,(,CF,),normal,human,sera,assayed,ability,inhibit,sodium-,dependent,glucose,transport,rat,brush-border,membrane,vesicles,.,Fresh,CF,age-,sex-matched,control,sera,inhibitory,compared,physiologic,saline,.,inhibition,CF,serum,44,+/-,13,%,(,mean,+/-,SD,),final,serum,concentration,6.7,%,,,67,+/-,34,%,10,%,serum,,,68,+/-,28,%,20,%,serum,.,ratio,inhibition,CF,sera,compared,control,sera,1.00,,,0.78,,,0.93,6.7,,,10,,,20,%,serum,concentrations,,,respectively,.,Although,slightly,greater,inhibition,CF,serum,observed,concentration,10,%,,,probably,significant,difference,could,detected,concentration,20,%,serum,.,Glucose,transport,presence,serum,sensitive,phlorizin,indicating,residual,glucose,transport,proceeding,sodium-dependent,glucose,transport,system,.,findings,suggest,CF,serum,specifically,inhibit,sodium-dependent,glucose,transport,system,.,intravesicular,space,accessible,glucose,reduced,presence,CF,control,serum,.,Fresh,CF,serum,1.4,times,effective,fresh,control,serum,(,P,less,0.01,),.,presence,substantial,vesicle-,shrinking,activity,control,serum,indicates,activity,considered,specific,CF,.
Documento 122,importance,intracellular,calcium,(,Ca,),secretion,transmembrane,ion,movement,led,us,study,Ca,cells,patients,cystic,fibrosis,(,CF,),lethal,genetic,exocrinopathy,.,Skin,fibroblasts,patients,CF,,,obligate,heterozygotes,(,HZ,),,,age-,sex-matched,controls,(,C,),used,matched,pair,experiments,measuring,45Ca,exchange,efflux,cells,time,.,CF,cell,lines,HZ,cell,lines,exhibit,increased,45Ca,exchange,compared,respective,controls,(,P,less,0.005,),.,magnitude,difference,(,approximately,30,%,),reduced,cells,washed,lanthanum,chloride,exchange,period,.,difference,likely,attributable,altered,capacity,one,intracellular,Ca,sequestering,organelles,.,evidence,explanation,seen,45Ca,efflux,experiments,CF,cells,retained,higher,percent,initial,0-time,45Ca,C,cells,late,efflux,period,(,P,less,0.05,),.,finding,altered,Ca,pool,size,CF,particularly,HZ,cells,suggests,altered,Ca,metabolism,related,basic,gene,defect,CF,.
Documento 123,Immunochemical,functional,properties,control,Cystic,Fibrosis,(,CF,),alpha,2-Macroglobulin,(,alpha,2M,),compared,.,Crossed,immunoelectrophoresis,Ouchterlony,double,diffusion,revealed,qualitative,differences,two,alpha,2-M,preparations,.,Trypsin-esterase,activity,assayed,BAPNA,substrate,,,presence,excess,STI,,,gave,similar,ratios,total,active,alpha,2M,.,alpha,2M-trypsin,complexes,equally,stable,various,experimental,conditions,maintained,constant,STI,non-inhibited,esterase,activity,.,Normal,CF-alpha,2M-trypsin,complexes,taken,normal,human,fibroblasts,similar,extent,four,hour,period,.,significant,difference,observed,uptake,alpha,2M,untreated,sera,examined,.,uptake,alpha,2M,CF,sera,always,lower,pooled,control,sera,despite,large,variation,.,Mixing,control,CF,serum,affect,normal,uptake,serum,components,taken,normal,extent,.,Intracellular,degradation,CF,alpha,2M,half,life,2.0,2.8,hours,,,compares,well,normal,half,life,2.2,hours,.,work,needs,done,nature,interaction,alpha,2M,proteases,reasonable,explanation,molecular,nature,abnormal,behavior,sought,.
Documento 124,report,presents,experimental,observations,indicating,presence,inhibitory,activity,cystic,fibrosis,(,CF,),serum,impairs,phagocytosis,Pseudomonas,aeruginosa,rabbit,well,human,alveolar,macrophages,.,49,patient,serum,samples,studied,,,40,consistently,showed,greater,equal,60,%,inhibition,,,3,showed,inhibition,6,range,20-60,%,inhibition,Pseudomonas,phagocytosis,.,parallel,studies,,,phagocytosis,S.,aureus,S.,marcescens,found,inhibited,CF,serum,.,Mixing,CF,serum,normal,serum,could,overcome,inhibitory,effect,,,indicating,presence,inhibitory,factor,rather,lack,necessary,component,.,inhibitory,activity,lost,upon,exposure,serum,glass,,,upon,freezing,serum,,,upon,heating,56,degrees,C,30,minutes,.
Documento 125,Serum,ciliotoxic,activity,(,SCA,),,,described,cystic,fibrosis,(,CF,),,,studied,mutant,mice,hereditary,alterations,resembling,inherited,disease,.,test,developed,detect,SCA,biologic,fluids,means,natural,vibratile,system,;,consisted,incubation,mouse,sperm,different,CF,serum,dilutions,controlled,conditions,,,order,determine,sperm,translation,cessation,time,(,STCT,),sperm,activity,cessation,time,(,SACT,),.,findings,study,similar,obtained,authors,employing,alternative,systems,,,decided,apply,method,mice,serum,.,Sera,obtained,male,female,3-,4-wk-old,mice,DBA/2J-cri,,,C57BL/6J-bgJ,,,BALB/c,inbred,strains,;,SCA,investigated,affected,homozygotes,+/,?,siblings,used,controls,.,Male,8-,16-wk-old,BALB/c,mice,employed,sperm,donors,.,Significant,differences,found,cri/cri,+/,?,mice,DBA/2J-cri,strain,STCT,SACT,determinations,1/10,serum,dilution,.,concluded,mouse,sperm,system,sensitive,enough,detect,SCA,biologic,fluids,human,beings,.,Likewise,,,test,mouse,sperm,allowed,us,detect,SCA,cri/cri,mice,,,turning,mutation,possible,animal,model,CF,.
Documento 126,Samples,plasma,serum,53,cystic,fibrosis,(,CF,),patients,,,90,relatives,CF,patients,,,159,controls,incubated,porcine,bovine,125I-trypsin,,,electrophoresed,polyacrylamide,gel,,,autoradiographed,.,individuals,,,main,binding,protein,125I-trypsin,shown,alpha,2-macroglobulin,(,alpha,2M,),.,Using,method,analysis,,,difference,electrophoretic,migration,125I-trypsin-alpha,2M,complexes,observed,CF,control,individuals,.,However,,,trypsin,binding,IgG,observed,80,%,CF,patients,,,30,%,mothers,,,3,%,controls,,,two,patients,affected,pancreatitis,.,trypsin,binding,immunoglobulins,called,TbIg,,,specifically,,,Tb1gG,referring,G,class,.,Experimental,evidence,indicates,binding,trypsin,IgG,occurs,Fab,portion,molecule,.,Tb1gG,must,antibodies,probably,induced,exogenous,trypsin,ingested,daily,CF,patients,(,patients,affected,chronic,pancreatitis,),.,Antibodies,porcine,pancreatic,elastase,observed,using,analysis,,,frequently,Tb1g,.
Documento 127,tracheal,ring,explant,system,,,used,25,%,cystic,fibrosis,(,CF,),serum,,,displayed,obvious,ciliostasis,.,Hamster,,,rabbit,,,guinea,pig,explants,measurable,decreases,ciliary,activity,24,hr,incubation,serum,.,differential,response,CF,serum,(,relative,normal,serum,),greatly,increased,using,explants,maintained,24-72,hr,minimal,essential,medium,(,MEM,),10,%,horse,serum,selected,basis,optimal,ciliary,activity,vigor,.,bioassay,system,guinea,pig,tracheal,explants,,,incubation,25,%,normal,serum,would,produce,essentially,change,relative,ciliary,activity,(,score,242,possible,300,),,,whereas,CF,serum,resulted,86,%,decrease,(,score,33,),.,Scanning,electron,microscopic,observation,indicated,explants,displaying,CF-ciliostatic,effect,significant,accumulations,mucous,ciliated,epithelial,surface,.,biochemical,viability,assay,(,dehydrogenase,activity,),showed,cytonecrosis,CF,serum-treated,tissues,compared,standard,explants,(,10,%,horse,serum,MEM,),control,explants,(,25,%,normal,human,serum,),.
Documento 128,effect,7,cystic,fibrosis,sera,4,normal,sera,investigated,37,cultures,ciliated,epithelium,rabbit,trachea,.,Serum,introduced,Rose,culture,chambers,concentration,10,%,volume,.,frequency,ciliary,beat,monitored,laser,light-scattering,spectroscopy,.,results,show,response,cilia,sera,well,characterized,laser,light,scattering,.,preliminary,evidence,suggests,early,increase,frequency,ciliary,beat,,,followed,rapid,arrest,ciliary,activity,,,sensitive,characteristic,response,produced,cystic,fibrosis,serum,,,normal,serum,.
Documento 129,Sera,100,subjects,tested,presence,cystic,fibrosis,(,CF,),``,factor,'',utilizing,short,circuit,current,rat,jejunum,bioassay,.,Comparing,mean,percent,decrease,short,circuit,current,,,presumed,normal,group,differs,homozygous,CF,group,P,=,0.001,heterozygous,group,P,=,0.05,.,two,CF,genotypes,statistically,different,P,=,0.004,.,,,however,,,large,overlap,among,three,groups,,,limits,assay,'s,utility,guide,factor,purification,well,clinical,use,.
Documento 130,relationship,activity,cystic,fibrosis,serum,ciliary,dyskinesia,factor,,,detected,rabbit,tracheal,bioassay,,,clinical,status,patient,investigated,children,,,1-24,years,old,,,cystic,fibrosis,.,significant,correlation,found,amount,serum,factor,activity,age,,,clinical,status,assessed,Schwachman,score,,,pulmonary,function,(,vital,capacity,,,functional,residual,capacity,,,total,lung,capacity,,,residual,volume,,,maximum,breathing,capacity,,,maximal,midinspiratory,flow,,,maximal,midexpiratory,flow,),blood,gas,levels,(,pCO2,,,pO2,),.,activity,showed,significant,relationship,serum,galactosyltransferase,activity,children,cystic,fibrosis,.
Documento 131,Ten,children,CF,matched,pairs,infused,either,Intralipid,10,%,glucose,double,blind,basis,every,week,one,year,.,Although,statistically,significantly,greater,gain,height,weight,study,year,compared,previous,year,test,group,,,groups,improved,expected,.,Cumulative,data,analysis,showed,greater,improvement,Intralipid,group,(,23,possible,45,points,),compared,glucose,group,(,-2,points,;,P,less,.02,),.,study,indicates,need,better,define,role,nutrition,pathophysiology,CF,.,Meanwhile,,,recommended,children,CF,plasma,linoleic,acid,levels,measured,least,yearly,,,levels,low,,,appropriate,supplements,given,.
Documento 132,roentgenogram,scoring,system,presented,useful,evaluation,follow-up,patients,cystic,fibrosis,.,system,shown,reproducible,observers,correlate,significantly,results,pulmonary,function,tests,,,Shwachman-Kulczycki,scores,,,,,short-term,evaluation,,,morbidity,.
Documento 133,Essential,fatty,acid,supplementation,oral,safflower,oil,(,1,gm/kg/day,),11,cystic,fibrosis,patients,(,aged,6,months,14,years,),one,year,produced,significant,change,sweat,chloride,concentration,(,mEq/liter,),sweat,rate,(,gm/min/m2,),,,Addition,vitamin,E,(,10,mg/kg/day,),safflower,oil,effect,sweat,chloride,concentration,rate,compared,placebo,.,clinical,improvement,could,detected,compared,control,group,.,results,support,previous,reports,effects,fatty,acid,supplementation,sweat,electrolyte,concentrations,cystic,fibrosis,.
Documento 134,records,children,Tucson,area,diagnosed,cystic,fibrosis,(,CF,),age,12,months,reviewed,ascertain,prevalence,metabolic,alkalosis,major,presenting,manifestation,CF,.,Five,eleven,infants,(,46,%,),CF,diagnosed,1,12,months,age,initially,seen,hypokalemia,,,hypochloremia,,,metabolic,alkalosis,unassociated,marked,dehydration,,,hyperpyrexia,,,major,pulmonary,and/or,gastrointestinal,symptoms,.,Two,infants,repeated,episodes,metabolic,alkalosis,;,one,infants,,,episodes,metabolic,alkalosis,occurred,diagnosis,CF,.,postulated,chronic,loss,sweat,electrolytes,together,mild,gastrointestinal,respiratory,illness,may,predispose,infant,cystic,fibrosis,severe,electrolyte,acid-base,disturbance,.,lack,shock,hyperpyrexia,together,apparent,chronicity,electrolyte,losses,differentiates,metabolic,alkalosis,heat,prostration,syndrome,,,acute,complication,cystic,fibrosis,.,Quantitative,sweat,testing,part,evaluation,infant,unexplained,metabolic,alkalosis,.,Serum,electrolytes,assessed,regularly,infants,cystic,fibrosis,hot,weather,months,.
Documento 135,review,2,000,autopsies,children,,,16,cases,extensive,necrosis,scarring,fibrosis,myocardium,found,.,lesions,involved,mainly,left,ventricle,spared,endocardium,,,pericardium,,,coronary,vessels,.,necrotic,fibrotic,heart,lesions,found,closely,associated,various,pancreatic,diseases,:,cystic,fibrosis,(,11,cases,),,,pancreatic,lipomatosis,(,2,cases,),,,extensive,small,bowel,resection,(,3,cases,,,2,associated,acute,interstitial,pancreatitis,),.,explain,unexpected,associations,,,two,hypotheses,put,forth,:,(,1,),lack,absorption,presently,undetermined,substances,indispensable,correct,trophicity,myocardium,,,(,2,),release,blood,proteolytic,enzymes,consecutive,activation,phlogistic,substances,kinins,.
Documento 136,procedure,described,permits,rapid,isolation,large,amounts,elastase,cathepsin,G,purulent,sputum,.,procedure,involves,:,(,1,),digestion,sputum,DNase,,,(,2,),extraction,insoluble,residue,remains,1,NaCl,,,pH,8,,,(,3,),affinity,chromatography,Sepharose-bound,Trasylol,,,(,4,),separation,two,enzymes,chromatogrphy,CM-Sephadex,.,Starting,500,g,sputum,possible,isolate,175,mg,two,enzymes,within,7,10,days,.,Active,site,titration,indicated,enzymes,least,97,%,pure,.,Disc,gel,electrophoresis,presence,absence,SDS,amino,acid,sequence,N-terminal,region,support,conclusion,elastase,cathepsin,G,isolated,sputum,identical,enzymes,isolated,directly,leukocytes,human,blood,.
Documento 137,shown,skin,fibroblast,patients,cystic,fibrosis,(,CF,),carriers,CF,[,heterozygotes,(,HZ,),],consume,O2,controls,.,mitochondrial,electron,transport,inhibitor,rotenone,added,cells,,,relative,inhibition,O2,consumption,CF,greater,HZ,greater,controls,(,P,less,0.005,comparisons,),.,rotenone,specifically,inhibits,NADH,dehydrogenase,,,[,NADH,:,(,acceptor,),oxidoreductase,,,EC,1.6.99.3,],,,enzyme,energy-conserving,site,1,mitochondrial,electron,transport,system,,,activity,kinetics,enzyme,system,studied,fibroblast,homogenates,.,NADH,dehydrogenase,activity,equal,cells,three,genotypes,.,pH,8.0,,,affinity,enzyme,substrate,CF,greater,HZ,=,controls,;,pH,8.6,,,affinity,CF,greater,HZ,=,controls,(,P,less,0.005,differences,),.,pH,optima,genotypes,without,exception,8.6,(,CF,),,,8.3,(,HZ,),,,8.0,(,control,),.,HZ,control,lines,distinguished,unequivocally,blind,test,basis,differences,pH,optima,.,Purified,mitochondrial,preparations,revealed,pH,optima,identical,found,whole,cell,homogenates,.,data,suggest,mutant,gene,responsible,CF,expressed,complex,mitochondrial,NADH,dehydrogenase,system,.
Documento 138,series,62,cases,cystic,fibrosis,presenting,Transvaal,Memorial,Hospital,Children,,,Johannesburg,,,10-year,period,1968-1978,,,15,patients,required,surgical,treatment,17,complications,disease,.,Meconium,ileus,,,rectal,prolapse,,,intussusception,ethmoiditis,commonest,surgical,presentations,,,portal,hypertension,,,bronchial,obstruction,nasal,polyposis,also,experienced,.,basic,defect,unknown,,,treatment,today,still,directed,towards,usually,unpredictable,secondary,consequences,.
Documento 139,bacteriological,effect,chemotherapy,Pseudomonas,aeruginosa,(,Ps.ae,.,),lungs,patients,cystic,fibrosis,reviewed,.,5-year,period,49,children,adults,treated,190,courses,different,antibiotics,.,mucoid,strains,Ps.ae,.,disappeared,72.0,%,courses,combination,tobramycin,carbenicillin,employed,.,Tobramycin,given,alone,bacteriological,effect,26.6,%,courses,.,Colimycin,alone,combination,carbenicillin,effect,.,18,patients,received,subsequent,courses,tobramycin,combination,tobramycin,carbenicillin,significant,difference,favour,combination,therapy,found,,,also,cases,many,precipitins,Ps.ae,.,serum,.,74.5,%,initially,successful,courses,patients,recolonized,Ps.ae,.,within,1,month,.,nephrotoxic,ototoxic,side,effects,demonstrated,spite,high,doses,tobramycin,(,10,mg/kg/24,h,),emmployed,repeated,courses,.
Documento 140,Bronchial,secretions,207,children,suffering,various,pulmonary,diseases,15,healthy,controls,tested,concentration,IgA,,,IgG,,,lactoferrin,lysozyme,.,results,obtained,suggest,many,cases,chronic,lung,diseases,children,levels,lactoferrin,immunoglobulins,,,especially,secretory,IgA,,,low,.,severe,infections,(,cystic,fibrosis,,,bronchiectases,),significant,increase,IgG,concentration,observed,.
Documento 141,concentration,immunoglobulins,,,lactoferrin,lysozyme,compared,bronchial,secretions,obtained,children,various,chronic,lung,diseases,.,IgG,,,lactoferrin,lysozyme,,,secretory,IgA,,,concentrations,shown,increased,chronic,inflammatory,response,.
Documento 142,Assays,based,counting,total,cells,colony-forming,cells,used,demonstrate,neither,dexamethasone,dibutyryl,adenosine,3',5'-monophosphate,(,cyclic,AMP,),kills,human,fibroblasts,variety,conditions,.,results,contradict,previous,studies,showing,dexamethasone,dibutyryl,cyclic,AMP,kill,higher,percentage,fibroblasts,normal,humans,individuals,cystic,fibrosis,.
Documento 143,Cultured,skin,fibroblasts,subjects,cystic,fibrosis,exhibited,normal,population,doubling,times,early,passages,.,13,cumulative,population,doublings,,,cystic,fibrosis,lines,doubled,slowly,controls,ceased,doubling,19,weekly,passages,.,Control,lines,continued,doubling,27,passages,.,premature,senescence,noted,cells,subjects,cystic,fibrosis,reconciles,controversial,observations,cell,doubling,reported,literature,.,Data,presented,demonstrate,experiments,cystic,fibrosis,cells,late,passage,may,generate,misleading,results,since,differences,control,lines,may,ascribed,generalized,senile,changes,rather,specific,results,cystic,fibrosis,genotype,.
Documento 144,early,diagnosis,cystic,fibrosis,better,management,patients,childhood,increasing,numbers,surviving,adult,life,.,main,problem,requiring,continuous,medical,care,older,cystic,fibrosis,patient,persisting,often,progressive,chest,disease,.,reason,cystic,fibrosis,clinic,adolescents,young,adults,started,Western,Infirmary,1975,.,paper,presents,observations,13,patients,attended,1975,1977,.,Eleven,patients,alive,well,shown,evidence,deterioration,period,.,Ten,school,regular,employment,.,optimum,medical,supervision,possible,give,young,adults,cystic,fibrosis,worthwhile,existence,.
Documento 145,``,Psychosocial,'',literature,cystic,fibrosis,(,CF,),critically,reviewed,.,Major,methodological,shortcomings,include,anecdotal,nature,findings,,,overemphasis,negative,consequences,disease,,,lack,suitable,theoretical,framework,.,Avenues,future,research,suggested,.
Documento 146,Apart,sound,physiologic,basis,distal,splenorenal,shunt,compared,portacaval,shunt,conventional,central,splenorenal,shunt,,,two,important,reasons,think,use,type,shunt,especially,advantageous,children,portal,hypertension,secondary,cystic,fibrosis,.,Firstly,,,thick,,,fibrotic,retroperitoneal,area,porta,hepatis,,,portacaval,shunt,constructed,,,avoided,,,makes,distal,splenorenal,shunt,easier,operation,.,Secondly,,,notwithstanding,relatively,small-sized,vessels,,,wide,anastomosis,constructed,high,flow,rate,,,therefore,,,minimal,chance,shunt,thrombosis,.
Documento 147,Tests,claimed,detect,small,airway,disease,evaluated,children,.,Fifty-two,subjects,normal,,,30,cystic,fibrosis,(,CF,),,,35,asthma,selected,basis,normal,spirometry,,,informed,consent,obtained,parents,.,Tests,undertaken,measurement,maximum,expiratory,flow,volume,curves,breathing,air,helium-oxygen,mixture,,,single,breath,nitrogen,washout,curves,,,lung,volumes,,,,,except,normal,subjects,,,measurement,arterial,oxygen,tension,.,Closing,volumes,normal,children,CF,asthma,,,whereas,slope,alveolar,plateau,abnormal,83,%,.,Maximum,expiratory,flow,rate,50,%,total,lung,capacity,reduced,65,%,maximum,mid-expiratory,flow,rate,57,%,;,residual,volume,increased,51,%,,,results,tests,abnormal,less,50,%,children,.,evidence,suggesting,lung,disease,patchy,children,mild,CF,interval,phase,asthma,.,tests,detect,specific,pathological,processes,small,airways,reflect,consequences,small,airway,abnormalities,,,may,vary,disease,well,different,diseases,.,one,test,alone,appears,useful,.,Together,contribute,understanding,functional,abnormalities,present,individual,.
Documento 148,25,children,(,13,male,;,12,female,),cystic,fibrosis,aged,6,months,16,years,24,matched,controls,total,serum,vitamin,E,levels,fatty,acid,patterns,serum,cholesterol,esters,,,phospholipids,triglycerides,demonstrated,.,Compared,controls,(,1.02,+/-,0.24,mg/dl,),total,serum,vitamin,E,levels,significantly,decreased,patients,cystic,fibrosis,(,0.30,+/-,0.26,mg/dl,),(,p,less,0.01,),.,significant,difference,comparing,fatty,acid,patterns,serum,ester,fractions,groups,.,Differences,seen,best,cholesterol,ester,fraction,.,fraction,linoleic,acid,shows,trend,decreased,cystic,fibrosis,patients,compared,control,group,.,possible,influence,height,velocity,levels,essential,fatty,acids,discussed,.
